Next Article in Journal
How Do Quality of Life (QoL) and Symptom Burden Evolve in Inpatient Palliative Care (PC) Patients following One Week of Care in a Specialized Palliative Care Unit (PCU)? A Comparison of Two Groups, with One Receiving Specialized Outpatient Palliative Care Prior to Admission
Previous Article in Journal
Imiquimod Is Effective in Reducing Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Can Asiatic Acid from Centella asiatica Be a Potential Remedy in Cancer Therapy?—A Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

An Overview of the Spices Used for the Prevention and Potential Treatment of Gastric Cancer

by
Katarzyna Kostelecka
1,
Łukasz Bryliński
1,
Olga Komar
1,
Justyna Michalczyk
1,
Agata Miłosz
1,
Jan Biłogras
1,
Filip Woliński
2,
Alicja Forma
2,* and
Jacek Baj
1
1
Department of Anatomy, Medical University of Lublin, ul. Jaczewskiego 4, 20-090 Lublin, Poland
2
Department of Forensic Medicine, Medical University of Lublin, ul. Jaczewskiego 8b, 20-090 Lublin, Poland
*
Author to whom correspondence should be addressed.
Cancers 2024, 16(8), 1611; https://doi.org/10.3390/cancers16081611
Submission received: 10 March 2024 / Revised: 15 April 2024 / Accepted: 18 April 2024 / Published: 22 April 2024
(This article belongs to the Special Issue Cancer and Nutrients)

Abstract

:

Simple Summary

Despite the significant improvements in the diagnosis and therapeutic strategies for gastric cancer, this malignancy still remains one of the most prevalent worldwide, with a significant mortality rate. Recently, the number of studies concerning herbal medicine and its use in various cancers has increased significantly. For example, there has been research focusing on its applications alone or in combination with other therapeutic strategies, such as chemotherapy. Therefore, because of the continuous research on newer spices, we aimed to summarize the current knowledge regarding the application of herbal medicine in gastric cancer patients, taking into account their potential as a part of potential cancer therapy. Besides providing a summary of the potential alternative therapeutic approaches for gastric cancer, the findings of this paper might provide insight into further research directions.

Abstract

Gastric cancer (GC) ranks third in terms of cancer-related deaths and is the fifth most commonly diagnosed type of cancer. Its risk factors include Helicobacter pylori infection, Epstein–Barr virus infection, the consumption of broiled and charbroiled animal meats, salt-preserved and smoke-enhanced foods, alcohol drinking, tobacco smoking, exposure to ionizing radiation, and positive family history. The limited effectiveness of conventional therapies and the widespread risk factors of GC encourage the search for new methods of treatment and prevention. In the quest for cheap and commonly available medications, numerous studies focus on herbal medicine, traditional brews, and spices. In this review, we outline the potential use of spices, including turmeric, ginger, garlic, black cumin, chili pepper, saffron, black pepper, rosemary, galangal, coriander, wasabi, cinnamon, oregano, cardamom, fenugreek, caraway, clove, dill, thyme, Piper sarmentosum, basil, as well as the compounds they contain, in the prevention and treatment of GC. We present the potential molecular mechanisms responsible for the effectivity of a given seasoning substance and their impact on GC cells. We discuss their potential effects on proliferation, apoptosis, and migration. For most of the spices discussed, we also outline the unavailability and side effects of their use.

1. Introduction

Gastric cancer (GC) causes 1 in every 12 deaths globally. According to Global Cancer Statistics for 2018, GC is responsible for over 1,000,000 new cases and 783,000 deaths worldwide. It ranks third in terms of cancer-related deaths and is the fifth most prevalent type of cancer to be diagnosed. GC usually appears after age 60. Men are two to three times more susceptible than women. Incidence rates in Northern America, Northern Europe, and African regions are generally low; GC is noticeably more frequent in Eastern Asia [1,2]. The etiology of GC is multifactorial (Figure 1) [3].
It has been estimated that more than 50% of the population worldwide carries the Helicobacter pylori (H. pylori) infection. The bacterium is capable of causing precancerous multifocal anthropic gastritis [4,5]. It can trigger the generation of reactive oxygen species (ROS), which can damage DNA and cause mutations and the hypermethylation of promoter CpG islands, which affects genes that prevent carcinogenesis, like the RPRM and TWIS1 [6]. Furthermore, virulent strains of H. pylori can carry the cytotoxic-associated gene A (CagA). In vivo, a protein produced based on the CagA gene disrupts intercellular junctions, decreases the polarity of epithelial cells, reduces apoptosis, and increases the proliferation of gastric cells. There are many more factors produced by H. pylori that may play a pivotal role in carcinogenesis (e.g., vacA s1/m1, vacA s1/m1/i1, or BabA) of GC [7,8].
Almost 10% of all GC can be related to Epstein–Barr virus (EBV) infection. In classification introduced by The Cancer Genome Atlas in 2014, this type of tumor was named EBV-associated gastric cancer (EBVaGC). EBVaGC is usually found in cardia and has a moderate or poor degree of differentiation and a better prognosis than EBV-negative GC [9].
The consumption of broiled and charbroiled animal meats and salt-preserved and smoked foods enhances GC progression. At the same time, fresh fruit and vegetables are considered protective. Also, the intake of N-nitroso compounds found in tobacco smoke, chewing tobacco, and beer have been linked to GC. Moreover, potent amplifiers of GC carcinogenesis are ethylene alcohol and tobacco smoking [10]. A higher risk of GC applies to some occupations, such as farmers, carpenters, tin miners, and steel workers. Exposure to ionizing radiation may also contribute [11].
Although only 10% of GCs show family aggregation, a positive family history is considered one of the most important risk factors. Hereditary diffuse GC resulting from cadherin 1 (CDH1) gene alternations is the most well-known type of familial GC. What is more, several studies documented an association between polymorphisms of genes involved in inflammatory response and GC carcinogenesis [4,10].
The standard treatment for localized GC is surgical excision (endoscopic in early GC or subtotal/total gastrectomy with D1/D2 lymphadenectomy) with perioperative and postoperative chemotherapy. Novel preoperative therapies (still studied) include the addition of anti-human epidermal growth factor receptor 2 (anti-HER2) and anti-vascular Endothelial Growth Factor (anti-VEGF) drugs, such as trastuzumab and pertuzumab, to standard FLOT protocol or use of the Programmed death-ligand 1 (PD-L1) inhibitors [12,13], and these are recommended for patients who undergo upfront surgery and T3-T4 grade adjuvant chemotherapy. Adjuvant chemotherapy is recommended for patients who undergo primary surgery with stage II/III disease. In the case of unresectable/metastatic GC, the first line of treatment is chemotherapy, sometimes in combination with immunotherapy [14,15].
The limited effectiveness of conventional therapies and the widespread risk factors of GC encourage the search for new methods of treatment and prevention. In the quest for cheap and commonly available medications, numerous studies focus on herbal medicine, traditional brews, and spices.

2. Spices for the Prevention and Potential Treatment of GC

Spices with potential use in the prevention of GC are turmeric, ginger, garlic, black cumin, black pepper, galangal, coriander, wasabi, oregano, fenugreek, caraway, clove, dill, thyme, and Piper sarmentosum (Table 1). Spices with potential for treatment include turmeric, ginger, garlic, black cumin, chili pepper, saffron, black pepper, rosemary, galangal, coriander, wasabi, cinnamon, oregano, fenugreek, caraway, clove, dill, thyme, and basil (Table 2).

2.1. Tumeric

Tumeric is one of the species that had potential anticancer activity; turmeric includes curcumin. According to Zhend et al. [43], this polyphenolic compound could be applied in the treatment of nasopharyngeal cancer, lung cancer, hepatobiliary cancer, breast cancer, colorectal cancer, prostate cancer, cancer of the uterus, hematopoietic tumors and GC [43]. Due to its hepatoprotective, hepatic steatosis-inhibiting, anti-fibrotic effects, curcumin is also a potential therapeutic option in the prevention and treatment of liver and biliary tract diseases [123].
The potential anticancer activity of curcumin is associated with inhibiting proliferation and migration, inducting the apoptosis of GC cells, which can be reached by different pathways [124]. One of them is the inhibition of the expression of sonic hedgehog homolog (Shh), GLI Family Zinc Finger 1 (Gli1), and Forkhead box protein M1 (Foxm1) in the Shh signaling pathway and the inhibition of the expression of β-catenin in the Wnt signaling pathway. In this mechanism, curcumin suppresses the Shh and Wnt signaling pathways, which is associated with lower ability proliferation, migration, and invasion of cancer cells [57]. At the same time, the research by Hongbing et al. carried out on cell lines showed that curcumin may activate the P53 signaling pathway and inhibit the tophosphatidylinositol-3 kinase (PI3K) signaling pathway [58]. Curcumin also can affect the epigenetics of GC. In the study from 2019, curcumin presented a histone-modulating mechanism based on the regulation of histone acetylation and deacetylation enzyme activity. By the inhibition of histone deacetylases (HDACs) and histone acetyltransferases (HATs), curcumin suppresses proliferation and induces the apoptosis of GC cells [59]. The other epigenetic modification is the expression of MicroRNA34 (miR34). The downregulation of mir34 expression may be engaged in GC development: a lower level of miR34 in GC cells promotes proliferation and inhibits apoptosis [60]. Curcumin could significantly increase the level of miR34. The study carried out on cell lines showed that the elevation of the miR34 level inhibits proliferation and induces the apoptosis of GC cells [61]. MiR33b is also involved in GC tumorigenesis; in this case, curcumin, by increasing the expression of this molecule, stimulates GC cell apoptosis [62]. On the other hand, miR21 is a molecule, and its increased levels can be engaged in GC development. A study from 2018 showed that curcumin decreases its expression and has an antitumor effect [63].
Curcumin also seems to be usable in the prevention of GC. Its anti-inflammatory, antioxidant, and protective effects may be useful in inhibiting damage to the gastric mucosa by various agents such as non-steroidal anti-inflammatory drugs (NSAIDs) and stress bleeding [16,17]. Moreover, curcumin has antibacterial properties, which are associated with the inhibition of HP infection [18,19]. The study carried out on the mice model showed that curcumin downregulates the expression of inflammatory cytokines and chemokines as toll-like receptors (TLRs) and (myeloid differentiation primary response 88) MyD88 [125].
One of the biggest advantages of curcumin is its safety. The studies carried out on humans and animals showed that turmeric and curcumin are nontoxic [126,127]. Despite this, its bioavailability is a problem. The problem with its poor solubility, low absorption, rapid metabolism, and rapid systemic elimination poses a threat to its therapeutic potential [128]. Therefore, improving bioavailability is important. One of the proposed methods is N-carboxymethyl chitosan (NCC)-coated curcumin-loaded modified solid lipid nanoparticles (NCC-SLN), by which, through the mechanism of inhibition, the rapid release of curcumin in an acidic environment enhances the bioavailability of curcumin [129]. The other option is the curcumin in casein nanoparticles (CasNPs), which also improves the bioavailability of curcumin [130]. Ligand-modified curcumin liposomes are a promising method for increasing the bioavailability of curcumin. Their use not only increases the bioavailability of curcumin but also improves the therapeutic effect [131]. Future research should focus on improving the bioavailability of curcumin [132].

2.2. Ginger

Ginger is a herbaceous plant known since ancient China. As many as 400 bioactive compounds have been isolated, some of which have anticancer properties [133,134].
One of them is a phenolic compound, 6-gingerol, which is the main active compound isolated from ginger. In the study by Youjun et al. [64], 6-gingerol showed potential usefulness in increasing the radiosensitivity of GC cells. The effect of 6-gingerol was to inhibit GC cell proliferation, enhance IR-induced cell arrest at the G2/M stage, and induce apoptosis. Moreover, due to its potential ease of obtaining and widespread occurrence, it seems that 6-gingerol may have potential use as a radiosensitizer, but further research is needed [64]. The effect of 6-gingerol on cisplatin chemotherapy was also investigated. It was shown that 6-gingerol increased the sensitivity of GC cells to cisplatin by arresting the cells at the G1 stage. Moreover, the use of 6-gingerol inhibited the migration ability of GC cells, and the combination of cisplatin and 6-gingerol caused not only the inhibition of migration but also the proliferation of cancer cells [65]. Furthermore, in a study carried out on rats, ginger extract and ginger juice appear to be useful in alleviating nausea and vomiting and the inhibition of gastric emptying induced by cisplatin treatment [66]. The other compound, which can be found in ginger and has a potential anticancer property, is 8-paradol. This compound induces the apoptosis of cancer cells by promoting the mitophagy of cells with promoted PINK1/Parkin-associated mitophagy. 8-paradol also inhibits GC cell proliferation [67].
Ginger is also used in the prevention of GC. Steamed ginger extract showed anti-inflammatory effects: it inhibited the synthesis of interleukin (IL)-8, tumor necrosis factor α (TNF-α), IL-6, inducible NOS (iNOS), and interferon-gamma (IFN-γ); inhibited the Nuclear factor kappa B (NF-κB) signaling pathway; and also reduced the production of nitric oxide and activity myeloperoxidase in gastric epithelial cells infected with H. pylori. Due to this, ginger extract can inhibit acute gastritis, chronic inflammation of the mucosa and submucosa, cryptitis, as well as the degeneration and erosion of epithelial cells caused by H. pylori [20,21]. Ginger extract has a synergistic effect with clarithromycin and has also shown activity against antibiotic-resistant strains of H. pylori [22].
Information on the bioavailability of compounds contained in ginger is limited. After administration, they are quickly absorbed, accumulate in many tissues, and are intensively metabolized, which is why they are excreted in the form of metabolites in bile and urine [135]. An increase in the absorption of compounds contained in ginger extract can be achieved using the solid dispersion method [136]. Another option is to use castor oil as a nanostructured lipid carrier, which improves the bioavailability of ginger extract [137]. Ginger is described as safe to use and does not cause side effects [135].

2.3. Garlic

The health-promoting properties of garlic have long been known. The beneficial properties of garlic may be related to its immunomodulatory and anti-inflammatory effects, which are achieved through the stimulation of macrophages, lymphocytes, NK cells, dendritic cells, and eosinophils, as well as through mechanisms including the modulation of cytokine secretion, immunoglobulin production, phagocytosis, and macrophage activation. Garlic also exhibits antimicrobial, anti-arthritic, anticoagulant, anticancer, hypoglycemic, and hypolipidaemic effects.
The compounds it contains also have potential applications in the prevention and treatment of GC [68,69]. One of them is allicin. Its mechanism of action is to induce the apoptosis of GC cells in the mechanism of release of cytochrome from mitochondria, the hydroxylation of caspases, and the activation of the p38 mitogen-activated protein kinase (MAPK)/caspase 3 pathway [70,71]. The action of diallyl disulfide is associated with the arrest of GC cells in the G2/M phase of the cell cycle, induction of apoptosis, and inhibition of proliferation [72,73]. Another compound, diallyl trisulfide, also exhibits antitumor properties: it suppresses tumor growth and induces cell apoptosis in the mechanism of the activation of AMP-activated protein kinase (AMPK) [74]. Another compound is s-allilocysteine. It may find use in gastric ulcer healing due to its ability to inhibit the activation of inflammatory mediators: cyclooxygenase-2, prostaglandin E2, IL-1β, TNF- α, IL-6 [75,76].
Garlic supplementation appears to have a beneficial effect on reducing the risk of death from GC [77]. Interestingly, a 2020 study carried out on 3365 residents of a high-risk region for GC found that garlic supplementation had a beneficial effect on GC mortality, but only among non-drinkers [78]. At the same time, a study from 2012 showed that garlic supplements were associated with non-statistically significant reductions in GC mortality [79].
There is a lack of strong evidence regarding the use of garlic in the prevention of GC. On the one hand, according to a meta-analysis by Kodali et al. [23], the consumption of garlic has been shown to have a beneficial effect in the prevention of GC, but this is dose-dependent: higher garlic consumption provides a greater degree of protection. Moreover, easy availability and good taste make garlic consumption an easy method of GC prevention [23]. At the same time, the study by Hanseul et al. [24] found that garlic consumption reduces the risk of GC and also has no effect on H. pylori infection. Further research is needed to investigate the impact of garlic consumption in preventing GC [24].
Garlic does not present any side effects, but its drawback may be its intense smell. However, this can be overcome by using garlic-based supplements. Other advantages are its easy availability and good taste [23].

2.4. Black Cumin

Black cumin is well-known for its culinary uses, as well as its antioxidant, anti-inflammatory, immunomodulatory, anticancer, neuroprotective, antimicrobial, antihypertensive, cardioprotective, antidiabetic, gastroprotective, nephroprotective, and hepatoprotective properties, showing its potential medicinal value [138].
Black cumin contains thymoquinone, which has shown anticancer activity against GC. This compound can inhibit proliferation and induce apoptosis of GC cells. A 2017 study conducted on GC cell lines showed that thymoquinone inhibits the expression of key proteins of phosphatidylinositol-4,5-bisphosphate 3 kinase/protein kinase B/ mechanistic target of rapamycin (PI3K/Akt/mTOR) pathway [80]. Similar results were obtained in a study from 2023 carried out on the mouse model [81]. Another mechanism by which thymoquinone affects GC cells is the signal transducer and activator of the transcription 3 (STAT3) pathway. The inhibition of constitutive STAT3 phosphorylation resulted in the inhibition of the protein expression of STAT3 target gene products, such as survivin, cyclin-D, VEGF, and Bcl-2 (B-cell lymphoma 2), and the increased expression levels of Bax (Bcl2-associated X protein); this induced the apoptosis of GC cells [82]. Thymoquinone may also potentiate the effects of 5-fluorouracil (5-FU). In a study by Xiaofei et al. [83], it was shown that thymoquinone sensitizes GC cells to 5-FU, which enhances their apoptosis [83].
Black cumin also shows activity against H. pylori infection. A 2016 study used black cumin seeds in the eradication of H. pylori infection. Results showed that ground seeds at a dose of 2 g/d given together with 40 mg/d of omeprazole showed clinical activity against H. pylori, which may be comparable to the activity of triple therapy [25]. The effect of black cumin (6 g/day) in combination with honey (12 g/day) was also investigated. This combination also showed activity against H. pylori [26].
Despite its potential role as a compound found in black cumin, thymoquinone’s drawback is its poor water solubility, bioavailability, and stability [139]. The use of black cumin is associated with low toxicity, and the use of black cumin in the recommended doses is safe. Oral use has no adverse effect on liver or kidney function. The use of high doses over a long period and topically may lead to dermatitis; the use of high doses of 50–100 mg/kg drastically reduces the glutathione (GSH) concentration [140].

2.5. Chili Pepper

The chili pepper is a common spice used to enhance the flavor of food. It owes its characteristic pungent taste to the presence of capsaicin [141]. The effect of both this compound and chili peppers on GC is inconclusive. A 2014 study on GC cells showed that capsaicin inhibits proliferation and induces apoptosis of GC cells in a mechanism that modulates the expression of apoptosis-regulating proteins: it acts on the production of caspase-3 and reduces the expression of Bcl-2. In addition, it reduces the expression of phosphorylated extracellular signal-regulated kinase 1/2 (ERK 1/2), p38 MAPK, or c-Jun N-terminal kinase (JNK) [84]. An antitumor effect can also be obtained by affecting histone acetylation. This epigenetic effect is achieved by restoring the activity of hMOF HATs, resulting in the inhibition of GC cell proliferation [85].
On the other hand, the consumption of chili peppers may be a potential risk for GC; a meta-analysis by Lei et al. [86] showed a positive correlation between the consumption of significant amounts of chili peppers [86]. Similar results were obtained in the study from 2003: the consumption of large amounts of capsaicin (90–250 mg of capsaicin per day) may be an independent factor in GC [87]. In a case–control study, it was also shown that people who consumed chili peppers had a higher risk of GC than non-consumers [88]. The opposite conclusion was reached by Changchang et al. [142]; in their meta-analysis, they found no association between chili pepper consumption and increased GC risk [142]. The effect of capsaicin on the development of GC requires further research. They need to take into account other carcinogens in the diet and environment and the use of capsaicin of known purity [143].
The potential use of capsaicin is also hampered by its poor bioavailability (capsaicin has a short biological half-life in plasma and is rapidly eliminated from the body) and poor water solubility. In addition, it can cause several side effects: skin redness, painful hypersensitivity, nausea, intense tearing of the eyes, conjunctivitis, eyelid spasm (prolonged, forced, involuntary closing of the eyelids), vomiting, abdominal pain, stomach cramps, bronchospasm, and burning diarrhea in patients [144].

2.6. Saffron

Saffron is extracted from the dried flowers of the crocus (Crocus sativus L.) and used in the kitchen as a spice that imparts color, flavor, and aroma to food and drinks but is also credited with medicinal properties [145].
The main constituents contained in saffron are crocins (glycosidic derivatives of crocetin), picrocrocin (responsible for the bitter taste), and safranal, which is formed by the dehydration of picrocrocin during storage, giving the spice its characteristic aroma [146,147,148].
Given the reports of saffron’s medicinal properties, whether acting as an antioxidant or inducing an inhibitory effect on cancer cells [149], it has also been studied for its anticancer effects in GC. In a study conducted on rats with previously induced GC treated with saffron aqueous extract (SAE) by intraperitoneal (IP) injection for 50 days, it was proven that plasma antioxidant activity increased after SAE administration in a dose-dependent manner. SAE treatment also reduced serum lactic acid dehydrogenase (LDH) levels and, as a result of higher doses of SAE, induced apoptosis in GC tissue. Furthermore, a pathomorphological study showed that SAE treatment significantly reduced the histological severity of Methyl-N-Nitro-N-Nitrosoguanidine (MNNG)-induced lesions in the gastric mucosa [150]. Other studies have already focused on specific saffron constituents and their antitumor effects. One of these is crocin, which has shown an inhibitory effect on GC cell proliferation. The inhibition of GC cell proliferation increased with a higher dose of crocin. Crocin was also found to reduce the expression of TPM4, whose increased expression is found in GC. However, the overexpression of TPM4 abrogates the inhibitory effect of crocin on tumor cell proliferation. Therefore, with concomitant treatment with crocin, it is worthwhile to use Knockdown TPM4, which will enhance the inhibitory effect on tumor cell proliferation [89]. Another study also confirmed the inhibitory effect of crocin on GC cell growth; crocin also increased Bax expression and decreased Bcl-2 expression in GC cells. The increase in the Bax/Bcl-2 ratio after crocin treatment indicates the stimulation of apoptosis [90]. A study in rats also confirmed the ability to promote apoptosis as well as inhibit proliferation in MNNG-induced GES-1 cells. Crocin was also shown to protect via the Nrf2/Hippo signaling pathway against MNNG-induced malignant transformation [151]. Another study, using human GC cell lines, showed a crocin-induced decrease in Krueppel-like factor 5 (KLF5) and hypoxia-inducible factor 1-alpha (HIF-1α) expression, which is increased in GC tissues and cells. Interestingly, crocin decreases KLF5 expression by increasing miR-320 levels. Unfortunately, increasing KLF5 expression impairs crocin function and increases HIF-1α expression. In contrast, crocin treatment also led to a significant reduction in the number of migrating and invasive GC cells [152].
In addition to crocin, crocetin was also analyzed. A study in 30 rats showed a significant dose- and time-dependent inhibition of GC cell proliferation following crocetin administration. After treatment with crocetin, serum antioxidant capacity increased, and LDH activity decreased. A histopathological study showed that tumor lesions in the stomach tissue of crocetin-treated rats were significantly reduced [91]. Another study showed that crocetin may have an inhibitory effect on angiogenesis. The study also observed that crocetin inhibited cell proliferation and migration, affecting vessel formation [92].
The side effects of saffron have not yet been described in GC, but when used, for example, in a study for the treatment of depression, anxiety, and other psychiatric disorders, the following were mentioned: nausea, decreased appetite, anxiety, and headache. With the use of crocin, manometric hemorrhage, dyspnea, and agitation were present [153].
To assess the toxicity of saffron, the toxicity of the saffron component safranal was investigated in mice and rats. Weakness, anorexia, decreased food and water intake, and weight loss were observed, which were significant at higher doses. On microscopic examination of the organs, abnormalities appeared in the kidneys, where edema and cytolysis were found. Progressive emphysema and lymphocyte infiltration were found in the lungs. Hematological studies showed a significant decrease in red blood cells, hemoglobin, hematocrit, and platelets in the treatment groups. However, in biochemical parameters, there was an increase in LDH and serum urea nitrogen (BUN) levels in the treatment groups and a decrease in total cholesterol, triglycerides, and alkaline phosphatase (ALP). Safranal showed greater toxicity after intraperitoneal administration compared to oral administration, which may be due to the greater first-pass effect and lower absorption rate during oral treatment [154]. In contrast, a 2013 study showed serious side effects, a decrease in amylase activity, a shortening of PTT, and a decrease in MXD levels (monocytes, basophils, and eosinophils) [155]. In another safety assessment of saffron tablets in healthy volunteers, apart from changes in some hematological parameters (reduction in red blood cells, hemoglobin, hematocrit, and platelets) and biochemical parameters (increase in sodium, blood urea nitrogen, and creatinine) further within normal limits, no serious side effects were shown [156].

2.7. Black Pepper

Black pepper, known as the ‘king of spices’, is obtained by drying the unripe fruit of Piper nigrum L. Both whole and lightly crushed peppercorns are used in cooking to improve the flavor of dishes [157].
The main active ingredient in pepper is alkaloid piperine (PIP), which is responsible for the pungent taste and also exhibits several medicinal properties such as antioxidant, anticancer, and anti-inflammatory effects [158]. PIP has shown potential for use in colorectal cancer [159], breast cancer, and melanoma [160]. Our review will focus on its use in GC.
The effect of PIP on cell proliferation and apoptosis has been investigated. It was proven that a higher dose of PIP caused an increase in the rate of inhibition of cell proliferation and also increased apoptosis. PIP treatment promotes the production of intracellular reactive oxygen species. Their excess can induce the apoptosis of cancer cells. Furthermore, PIP decreases the mitochondrial membrane potential, indicating a link between its pro-apoptotic effect and mitochondrial apoptosis. After treatment, a decrease in the expression of Bcl-2, a key protein of the mitochondrial apoptosis pathway, was also observed, with a concomitant increase in the expression of Bax. PIP also showed an effect on other important proteins of the mitochondrial apoptosis pathway, caspase-3 and caspase-9, by increasing their levels [161]. Another study confirmed the inhibition of proliferation and the induction of apoptosis of human GC cells by PIP through the inhibition of the PI3K/Akt signaling pathway. Piperine increased caspase-3 activity in GC cells. In a study of mice treated with PIP treatment, the inhibition of heterotopic tumor growth was noted. Additionally, PIP showed no toxicity during the 18-day treatment [93].
PIP also showed anti-inflammatory effects. In a study, piperine was found to inhibit IL-6-induced IL-1β expression via the inhibition of STAT3 and p38 MAPK activation. GC is characterized by a high expression of IL-6, and this high IL-6 production positively affects the aggressiveness of GC and also reduces the prognosis of patients. Because IL-6 increases cell invasiveness, piperine, by downregulating IL-6 expression, will counteract this invasion [94]. PIP has also shown anti-inflammatory effects in chronic gastritis in Mongolian gerbils, which was caused by H. pylori, one of the causative agents of GC. This study demonstrated that PIP reduces the number of H. pylori colonies. PIP was also found to reduce levels of the inflammatory cytokine IL-1β and increase the anti-inflammatory IL-10 in H. pylori-stimulated cells. The microscopic examination of the gastric mucosa showed an inhibition of neutrophil and mononuclear cell infiltration in the antrum and corpus [27]. PIP has shown an inhibitory effect on the growth and adhesion of H. pylori to GC cells and reduces motility by suppressing the expression of the flhA gene, which encodes an integral component of the flagellar membrane, and the flgE gene, which encodes a flagellar hook component [28]. Another study showed that PIP also inhibits the translocation of H. pylori toxins (VacA) to GC cells and reduces the secretion of IL-8, high levels of which are found in H. pylori infection. In infection, bacteria enter the intercellular space through cleavage of the E-cadherin ectodomain, while β-catenin accumulates in the nucleus. It has been demonstrated that PIP both inhibits E-cadherin cleavages and reduces β-catenin expression, which could be used to prevent GC initiation [29].
In addition to its numerous therapeutic effects, another advantage of PIP is that it is a safe substance. This is confirmed by a 90-day study carried out on rats during which no significant adverse effects were demonstrated. However, due to the dose-dependent increase in cholesterol levels, 5 mg PIP/kg body weight/day is considered a safe dose [162]. PIP has also not shown genotoxicity [163]. The only toxic effect frequently indicated is adverse reproductive effects in males (impaired spermatogenesis) when piperine is used in bolus doses of 10 mg/kg body weight/day [164]. However, in a study of 60 days in mice administered PIP, it was shown that after a withdrawal period (120 days), the changes were reversible [165,166].
Studies have also shown that PIP interacts with a variety of drugs, leading to the improved bioavailability of test drugs, which may be associated with a risk of adverse drug reactions [164].
The clinical efficacy of PIP may be limited by its bioavailability due to its hydrophobic nature and poor water solubility [167]. A study in rats demonstrated that regardless of the route of administration of PIP (oral or intraperitoneal), approximately 97% was absorbed. Moreover, 3% of the administered dose was excreted in the feces, while no PIP could be detected in the urine. The study also demonstrates that PIP does not undergo any metabolic changes during absorption, as it was detected in both the serous fluid and the intestinal tissue of the rats tested. This was also confirmed by another study from 2007 [168,169].

2.8. Rosemary

Rosemary (Rosmarinus officinalis) is a popular spice native to the Mediterranean region. In addition to its use in cooking, rosemary has medicinal properties, including anticancer activity. The main constituents responsible for this property in rosemary are the diterpenes (carnosic acid, its derivative carnosol, and rosmarinic acid). Rosemary has been shown to be beneficial against colorectal cancer, pancreatic cancer, breast cancer, ovarian cancer, prostate cancer, and GC [170,171].
In a study using cell cultures of GC cell lines, crude rosemary fruit extract was proven to inhibit proliferation and induce the apoptosis of cancer cells. Rosemary stopped the cell cycle of GC cells at the G2/M stage, and this effect was greater when higher doses were used [172]. Another study tested the effect on GC of components of rosemary, particularly carnosol. Carnosol inhibits the growth of GC cells by inhibiting the autophosphorylation of RSK2 and the phosphorylation of its substrate, ATF1. The inhibition of RSK2 kinase activity occurred in a dose-dependent manner, with a greater dose. Carnosol also inhibited the cell cycle at the G2/M phase. In addition, an increase in the apoptosis of GC cells induced by carnosol was noted. A study was also conducted on mice, which were injected with GC tissues, and then one group was treated orally with carnosol. In this study, a reduction in the volume and weight of gastric tumors was observed, and treatment was given without significant weight loss. The expression of Ki-67 was investigated and was reduced, indicating an inhibition of proliferation [95].
Another compound in rosemary, sageon, has also been tested for its effect on GCs. It was found that sageon inhibits the growth and induces apoptosis of GC cells. It was also discovered that sageon downregulates the expression of Akt in GC cells, the increased phosphorylation of which affects the mechanism of resistance to cisplatin treatment. Therefore, sageon, by its action, could reverse the resulting resistance to cisplatin, which could be used in therapy [96].
Rosemary is considered to be a safe substance. In a study conducted on rats, no adverse effects, distressing symptoms, or mortality were observed. Furthermore, no changes were observed in biochemical tests, which demonstrates the low acute toxicity of rosemary extracts [173].

2.9. Galangal

The term galangal is used to describe the rhizomes of several varieties of this plant in the Zingiberaceae family [174]. It has its uses in cooking, traditional medicine, and cosmetics. Two varieties are most commonly described in the medical literature: Alpinia galanga and Alpinia officinarum [174,175,176,177]. Galangal is rich in phenolic compounds (acids and flavonoids), of which galangin is predominant. Other flavonoids include kaempferide, 3-methoxyl-galangin, kaempferol, and pinocembrin [178,179,180,181].
Galangin is a natural flavonoid compound [(3,5,7-trihydroxyflavone (C15H10O5)]. It exhibits anti-inflammatory, antimicrobial, antioxidant, antiviral, and apoptotic activities [30,31,32]. Research is being conducted on its use in the treatment of cancer, gastrointestinal diseases, diabetes, obesity, rheumatoid inflammation, arthritis, neuropathy, or osteoporosis [31,32].
It has been suggested that galangin may show promise in the treatment of GC. New studies indicate that galangin reduces the viability of the GC cell line MGC 803 by inducing early and late apoptosis, inhibiting cell proliferation, decreasing cell viability by modulating STAT3 activation, and increasing ROS production in vitro while showing low cytotoxicity to normal cells [31,97].
Cell apoptosis was associated with the decreased expression of Bcl-2 and caspase-3 (CASP3), increased protein expression of cleaved CASP3, and cleaved poly adenosine diphosphate-ribose polymerase (PARP) with no change in Bax expression in the GC cell line tested. It was observed that the substance caused a reduction in the expression of proliferating cell nuclear antigen (PCNA) and Ki67 mRNA and protein [31,97]. The effect of galangin on GC cell growth was also investigated in vivo by conducting a mouse study. A reduction in the ratio of p-JAK2/JAK2 (Janus-associated kinase) and p-STAT3/STAT3, protein expression of Bcl-2, CASP3, and Ki67 was demonstrated, while increased protein expression of cleaved CASP3 and cleaved PARP was observed [31,97]. A comparative study comparing the effects of galangin and quercetin on the SGC-7901 GC cell line showed greater efficacy of galangin, which inhibited cell growth, induced apoptosis, and reduced mitochondrial membrane potential (MMP). Apoptosis occurs through a mitochondrial pathway involving caspase-8/Bid/Bax activation [98]. Previous in vitro studies of human GC SNU-484 cells suggested that galangin slows their growth. The mechanism of action was related to morphological changes of the nucleus in the cells in question, where features of apoptosis associated with the decreased expression of Bcl-2 and Bcl-xl and the increased expression of the Bax protein were shown. Galangin increased the expression of caspase 3 and 9 (CASP9) and PARP polymerase while inhibiting ERK1/2 activity and stimulating c-Jun N-terminal kinases (JNK). It was also shown to increase the expression of ubiquitin carboxy-terminal hydrolase isozyme L1 (Uch-L1) while decreasing the expression of glutathione S-transferase P (GSTP), suggesting an antitumor effect of galangin by a particular mechanism [32]. One study showed that galangin likely inhibits the growth of MGC803 GC cells in vivo in nude mice and in vitro by suppressing the NF-κB pathway and enhancing autophagy. It was observed to inhibit cell viability, increase microtubule-associated protein 1 light chain 3 B (LC3 B), inhibit phosphorylation of proteins associated with the NF-κB pathway, and promote autophagosome formation in the cells tested [99]. An in vitro study on the human gastric adenocarcinoma (AGS) and L929 AGS cell lines showed that the aqueous extract prepared from the whole plant exhibited antiproliferative activity, especially when high concentrations of the preparation were used [182].
Based on studies conducted to date, it has been suggested that galangin produces a lesser cytotoxic effect compared to the 5-FU. Furthermore, studies in nude mice showed that, compared to 5-FU, galangin was not associated with significant weight loss [97].
No reliable studies on the bioavailability of galangin have been identified. It is suggested that further experiments are needed, and studies are being conducted to obtain extracts that are well absorbed from the gastrointestinal tract [176]. The use of galangin in clinical settings may be hampered by its characteristic chemical properties (as a 3-hydroxyflavone, it has low solubility in water) [31].
One study in rats reports that the substance can modulate the activity of cytochrome P450 (CYP) enzymes and, thus, may have the effect of improving the bioavailability of oral drugs [183]. The bioavailability of galangin is estimated to be 7.6% [175]. Other experiments conducted in rats indicate that the bioavailability of galangin is dependent on the route of administration of the substance. Oral administration had a lower bioavailability than intravenous administration. This is also confirmed by another study in mice where galangin was probably rapidly adsorbed and glucuronidated after oral administration [184].
H. pylori infection is associated with GC development [33]. The inhibitory effect of galangin on the secretion of IL-8 by human AGS cells infected with H. pylori and its antimicrobial activity has been demonstrated, confirming its anti-inflammatory effect [33,34].
An experiment was conducted to investigate the effect of galangin on its protective potential of GC against cancer development after benzoapirene induction. The results presented suggest that galangin administration prevented tumors in 37.5% of the animals. In the rest of the animals receiving galangin, significantly smaller tumors were observed, thus confirming the anticancer potential of the substance [35].

2.10. Coriander

Coriander (Coriandrum sativum) is a plant cultivated for its leaves and seeds, which are used in cooking, cosmetics, and medicine. There are reports of its anti-inflammatory and anticancer potential [185,186]. Coriander seeds contain phytochemicals such as geranyl acetate, linalool, and camphor. The anticancer potential is believed to be due to quercitin and linalool found in coriander [100,174,185,186,187,188].
Quercitin, which belongs to the flavonoids, occurs in various forms, the most common being glycosides and ethers: 3-O-glycoside of quercetin, quercetin 3-sulphate, quercetin 3-glucuronide, and quercetin 3′-methylether. The antioxidant, anti-inflammatory, antibacterial, and antiviral effects of the substance have been described. It also has its part to play in the treatment of cardiovascular diseases, cancer, metabolic disorders, and neurodegenerative diseases [189]. The exact molecular mechanisms of quercetin useful for GC therapy are being sought and require further research. It may interact through multiple biological pathways and processes [100,190,191].
It has been suggested that the substance has anticancer effects by inducing apoptosis, ferroptosis, necroptosis, and other forms of programmed cell death. In a study, quercetin was shown to have a concentration-dependent inhibitory effect on GC cell growth. The increased expression of pyroptosis proteins [Gasdermin D (GSDMD), Gasdermin E (GSDME), cleaved caspase-1 (CASP1), NLR family pyrin domain containing 3 (NLRP3)] and apoptosis markers (CASP3 and PARP) in quercitin-treated cells was also demonstrated [100]. The involvement of quercitin in the PI3K/Akt/P-gp (protein kinase B/P-glycoprotein) cascade was investigated in the oxaliplatin-resistant (OxR) GC cell line KATOIII/OxR. It has been shown to reduce tumor cell survival and contribute to oxaliplatin resistance (reduced P-gp expression and activity) [101]. Studies conducted on various GC cell lines using different doses of quercitin resulted in the following effects: the inhibition of proliferation, induction of apoptosis, inhibition of cell growth, and increased efficacy of chemotherapy with irinotecan/SN-38 (irinotecan/7-ethyl 10-hydroxy camptothecin) [102].
In an in vitro study conducted on the EPG85-257P cell line and its daunorubicin-resistant variant, EPG85-257RDB, quercetin was shown to have an antiproliferative effect on the cells tested. It is suggested that the substance may reduce the resistance of GC cells to daunorubicin [103]. In another study, quercetin was shown to be involved in the tumor necrosis factor (TNF) and IL-17 pathways, effectively targeting GC cells. It was found to inhibit GC cell division and promote apoptosis by affecting the tumor suppressor protein p53 gene (TP53), gene c-myc (MYC), and the tissue inhibitor of metalloproteinases (TIMP1) [104].
One study found that the use of quercitin was associated with reduced migration and the invasion of GC cells from the BGC823 and AGS lines. The reduced expression of urokinase plasminogen activator (uPA) and uPA receptor (uPAR) proteins was also observed [192]. A study conducted on GC stem cells attempted to establish the inhibitory effect of quercitin on their survival. The mitochondrial-dependent induction of apoptosis was observed (the activation of CASP3 and CASP9, downregulation of Bcl-2, and upregulation of Bax and cytochrome c (cyt-c)). The induction of apoptosis dependent on the blockade of PI3K-Akt signaling in gastric cancer stem cells (GCSCs) is a future target for gastric treatment [105].
Quercitin has low bioavailability and is poorly soluble in water. Research is being conducted into the use of quercitin glucosides, which are more bioavailable than the basic form. It is indicated that nano-quercitin has higher efficacy [189,191]. Another potential way to increase the bioavailability of quercetin is through cryopreservation and microencapsulation [193].
Coriandrum sativum was analyzed for the generation of ROS and IL-8 in H. pylori-infected AGS cells. The inhibitory effect of the extract in question on their production was demonstrated, which may suggest the usefulness of its use in gastrointestinal diseases, especially those associated with H. pylori [33].

2.11. Wasabi

Wasabi (Eutrema japonicum, Wasabia japonica) belongs to the Brassicaceae family and is a traditional spice used in cooking. In addition to its culinary value, wasabi is used in medicine due to its content of allyl isothiocyanate, flavonoids, phenylpropanoids, and carotenoids. Antiproliferative, anti-inflammatory, antioxidant, anticancer, neuroprotective, and antioxidant activities are indicated [194]. Of the substances contained in wasabi, two are being investigated for efficacy against GC cells; these are 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) and allyl isothiocyanate (AITC) [195,196,197].
AITC is formed by hydrolysis of glucosinolates from cruciferous vegetables, including wasabi [198]. Its inhibitory effect on AGS was already suggested in a study published in 1991 conducted on rats [64]. This study showed that the dietary administration of wasabi powder inhibited MNNG-induced AGS in rats [199].
A study in Taiwan showed that AITC can inhibit the migration and invasion of human AGS cells in vitro. The substance’s mechanism of action involved the inhibition of PI3K/Akt, uPA, and MAPK signaling pathways. Decreases in the levels and activity of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and vimentin [106,107] were observed. AITC was shown to reduce the viability of AGS and SNU-1 GC cells in vitro. The mechanism of action of AITC was to induce morphological changes in tumor cells [108].
AITC extracted from the leaves of wasabia japonica, when administered orally to H.pylori-infected gerbils, resulted in a reduction in symptoms and had no effect on body weight or gastric pH [36].
AITC is non-toxic and safe. It is used as an additive in food products [106].
The administration of a substance containing 6-MITC in high doses to healthy men has not resulted in any side effects [200]. AITC has a high bioavailability, with approximately 90% of the product being absorbed when taken orally [106]. To improve the solubility and stability of AITC, nano- and microemulsions are used, improving its antitumor activity [198].
Sulforaphane (SFN), present in wasabi, may also exhibit anticancer properties [201]. SFN is one of the isothiocyanates whose efficacy in the treatment of GC has been confirmed in vitro and in vivo in nude mice. Its action resulted in the inhibition of cancer cell activity through the induction of PDL-1 expression in diseased cells [109]. The effects of sulforaphane on glycolysis and proliferation of SGC7901 and BGC823 GC cells were also addressed, taking into account the role of the TBX15/KIF2C axis (T-box transcription factor 15/kinesin superfamily member 2C). The substance was found to inhibit GC cell proliferation by inhibiting glycolysis, which is mediated by the downregulation of pyruvate kinase muscle isozyme M2 (PKM2). In addition, the overexpression of TBX15 results in the inhibition of glycolysis and tumor cell proliferation [110]. The mechanisms of action of sulforaphane on nicotine-stimulated MMP-9 induction have been investigated, and the substance has been shown to inhibit MMP-9 expression by reducing ROS production, inhibiting p38 MAPK and ERK1/2 activation, which, in turn, inhibits Activating protein 1 (AP-1) and NF-κB activity [202]. It has been shown that SFN can inhibit GC cell autophagy through the activation of the miR-4521/PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3) pathway. The mediator miR-4521-dependent apoptosis in vitro was also observed [111]. Sulforaphane has been shown to have proliferation inhibitory, cell cycle arrest, and apoptosis induction abilities in GC cells. The suppression of SET and MYN-domain containing 3 (SMYD3) associated with the regulation of cysteine-rich angiogenic inducer 61 (CYR61) and myosin regulatory light polypeptide 9 (MYL9) was observed. SMYD plays an important role in the anticancer effects of SFN [203].

2.12. Cinnamon

Cinnamon is extracted from the inner bark of the cinnamon tree. The active compounds of cinnamon are eugenol, cinnamaldehyde, beta-caryophyllene, and beta-caryophyllene oxide [204].
Eugenol has an inhibitory effect on AGS cell proliferation. It is a strong oxidant and has a cytotoxic effect on cancer cells, being safe for non-cancerous cells [44]. Eugenol has anti-metastatic activities on AGS cell lines independent of p53, P21, and SMAD4. It also inhibits the secretion of the TGF-β type 2 isoform and the intracellular expression of TGF-β. Compared to capsaicin, eugenol is a weaker antiproliferative agent; however, it is more effective in SMAD4 null SW620 cells and the presence of TGF-β receptor inhibitor LY2109761 in the SW620 cell line [120]. Manikandan et al. [112] proved the antiproliferative effect of eugenol for nuclear factor-kappaB (NF-κB) family members ((NF-κB (p50 and p65), an inhibitor of kappa B alpha (IκBα), phosphorylated IκBα (p-IκBα), IκB kinase β (IKKβ)) and the NF-κB target genes that cause proliferation and cell survival, including those that promote (e.g., cyclins, PCNA) or inhibit (e.g., p53, p21, and Gadd45). The activation of NF-κB in N-methyl-N(‘)-nitro-N-nitrosoguanidine-induced gastric tumors correlated with increased levels of cyclins and PCNA while simultaneously reducing the expression of p53 and p21. In the mentioned study, the administration of eugenol to animals treated with MNNG changed this ratio, i.e., there was a decrease in substances responsible for cell cycle promotion and an increase in those responsible for cell cycle inhibition. This allows for limiting tumor growth in the process of carcinogenesis [112]. To enhance the activity of eugenol, other scientists created a range of eugenol β-amino alcohol and β-alkoxy alcohol derivatives, which were subsequently examined against cancer cell lines, specifically AGS. The results indicated that certain derivatives have stronger cytotoxic properties compared to eugenol, leading to a statistically significant decrease in cell viability. Neither of the molecules led to a decrease in viability in noncancerous cells, indicating their selectivity towards cancer cells. The researchers explained that the cytotoxic properties of the compounds were linked to the induction of apoptosis, as they activated caspases-3, -8, and -9 [121]. More importantly, the mutation of p53 is frequently observed in human cancers, leading to malfunctions in apoptosis and rendering cancer cells resistant to chemotherapy, such as in GC. The responsiveness of GC to chemotherapy has been demonstrated to diminish when p53 is absent. A Western blot analysis of pro-apoptotic markers showed that eugenol could stimulate caspase-8 and caspase-3 even when p53 was absent [113].
Cinnamaldehyde (CA) induces antiproliferative effects by reducing cell viability in a dose-dependent manner compared to the control across different types of GC cells. The findings revealed that CA induces endoplasmic reticulum stress and autophagic cell death by activating the PERK-CHOP signaling pathway, inhibiting G9a binding on the Beclin-1 and LC3B promoter, and disrupting the Bcl-2–Beclin-1 interaction in GC cells [114].

2.13. Oregano

Origanum vulgare, known as oregano, is a widely used aromatic plant.
Sri Renukadevi Balusamy et al. [115] evaluated oregano essential oil apoptotic effects against human stomach cancer cell lines. They extracted four major components from oregano oil: thymol, ρ-cymene, γ-terpinene, and carvacrol. When the cells were treated with different concentrations of the tested spice, reduced cell numbers were recorded, so this scientific report proves the potential antiproliferative effect of oregano essential oil (EO) in a dose-dependent manner. EO extracted from this plant also caused a decrease in the ability to migrate human GC cells, while the control cells had not lost this possibility. Cancer cells can grow more easily than healthy cells; therefore, they need more energy than healthy cells, which is obtained during the activation of de novo fatty acid synthesis. To evaluate the molecular mechanism involved in cancer cell death, they investigated genes involved in the fatty acid and cholesterol biosynthesis pathway, specifically 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), Acetyl CoA synthase (ACC), sterol regulatory element-binding protein (SPREPB1), and fatty acid synthase (FASN). The expression of pathway genes like HMGCR, ACC, SPREPB1, and FASN showed a decrease in both transcript profile and protein accumulation, leading to the inhibition of GC cell growth. Moreover, oregano EO triggered the activation of Bax (a pro-apoptotic protein), reduced the levels of BCL2 (anti-apoptotic proteins), and, consequently, induced apoptosis via the mitochondrial pathway [115].
Another study initiated by Ayse Günes-Bayir [53] showed the cytotoxic, genotoxic, apoptotic, and ROS-generating effects of carvacrol (5-isopropyl-2-methylphenol) against the human AGS in the in vitro system. There was a positive correlation observed between the increasing dosage of carvacrol and the relative ROS levels in GC cells, leading to a pro-oxidant condition and induction of apoptosis thereafter. Moreover, Western blot analyses of carvacrol-treated cells suggested that the tested compound induces apoptosis, decreasing the Bcl-2/Bax ratio [53]. Carvacrol may become a new anticancer compound, but it is not selective towards pathological cells, as investigators proved by comparing its effects on GC cells to those on normal human fibroblast [205]. A recent study performed by the above-mentioned author investigated the clinical significance of this compound in a normal stomach, this time in an in vivo system. Low doses of carvacrol (10 and 25 mg/kg body weight) can prevent the toxic effects of MNNG by reducing the expression of caspase-9 and Bax and the high expression of Bcl-2 protein levels. The expression levels of caspase-9 and Bax proteins were notably elevated in the group with high-dose carvacrol (100 mg/kg BW carvacrol and MNNG) in comparison to all other groups. This observation might indicate the potential apoptotic activity of carvacrol at high doses. However, a biochemical analysis was performed to determine which dose of carvacrol provided the best protection against GC. The results of serum and tissue analyses of cytokines (IL-1β, IL-6, and TNF-α) and other investigated inflammatory mediators (VEGF and TGF-β) suggest that carvacrol can significantly reduce inflammation in low doses (10 mg/kg BW). We know that a large number of reports have shown that systematic inflammation plays a significant role in carcinogenesis, so this result is valuable to the scientific world. The authors reported that carvacrol at low doses showed a significant chemopreventive effect against GC in rats [37].
With the increased use of two compounds, carvacrol and thymol, in the food industry, people may be increasingly exposed to them orally. Lots of studies have focused on their beneficial effects, but according to the researchers, they may also have toxic action. The digestive tract, especially the stomach, would be the first target of these agents consumed by humans. Investigators indicated that these compounds should be used carefully in the food industry; therefore, further studies on their safety for human health are needed [206]. Recently, it was documented that higher doses of the phenolic compound, which is thymol, may equally harm cancerous and healthy cells, but administering low doses seems to protect healthy cells without losing its anticancer effect [207].

2.14. Cardamom

Cardamom belongs to the Zingiberaceae family, like turmeric and ginger. His main bioactive compounds are as follows: 1,8-cineole, α-terpinyl acetate, nerolidol, sabinene, g-terpinene, α-pinene, methyl linoleate, α-terpineol, β-pinene, n-hexadecanoic acid, and limonene [208].
Manjunath et al. [209] studied cardamom oil, lemon oil, and jasmine oil for their cytotoxic activity against human skin, gastric, and brain cancer cell lines. Unfortunately, cardamom oil (Elettaria cardamomum) showed stronger cytotoxicity against skin cancer cell lines only, but it did not show an inhibition of stomach cancer cell growth [209]. Another study initiated by Samir Qiblawi et al. [38] showed the protective effect of cardamom against forestomach chemical carcinogenesis. This study investigated the chemopreventive potential of cardamom against benzo(a)pyrene [B(a)P]-induced forestomach papillomagenesis in mice. The results showed that treatment with cardamom [(B(a)P + cardamom)] significantly reduced tumor incidence and multiplicity by 41.67% and 74.55%, respectively, compared with the B(a)P control group. Because cardamom was administered before the onset of cancer, its effect can be considered to be preventive on the development of B(a)P-induced forestomach papillomagenesis. The potential chemopreventive properties of cardamom may be ascribed to its ability to modulate phase II detoxifying enzymes, particularly glutathione-S-transferases (GST); activate antioxidant enzymes; elevate GSH levels; and inhibit lipid peroxidation levels as well as LDH activity. No adverse effects on ingestion of cardamom were detected. In conclusion, it seems reasonable to consume cardamom as a preventive agent against stomach cancer [38].

2.15. Fenugreek

Fenugreek seeds contain simple alkaloids, which consist mainly of trigonelline, choline, gentianine, and carpain. Other constituents include saponins, steroidal sapogenins, and flavonoids such as quercetin, luteolin, vitexin cinnamate, vicenin, and isovitexin, which are believed to support the anticancer effects of fenugreek [210].
Diosgenin, a major sapogenin found in fenugreek seed, has shown high potential and interest in the treatment of various cancers such as GC [211]. Previous studies have shown that diosgenin has effects that inhibit mesoderm posterior 1 (MESP1) expression, leading to suppressed proliferation of GC cells via inducing alternative reading frame (ARF) expression. MESP1 belongs to the family of transcription factors and promotes the proliferation of GC cells by inhibiting the expression of ARF, which is a tumor suppressor in human cancer. Therefore, diosgenin could be a potential natural product for the treatment of GC [116]. Another hallmark involved in carcinogenesis is invasion and metastasis. Interestingly, Mao et al. [117] showed that diosgenin could have an anti-invasion effect on GC cells because it may significantly enhance the expression of cell adhesion molecules, including E-cadherin, an invasion suppressor molecule. In addition, when combined with HIF-1α-specific short hairpin RNA (shRNA), diosgenin can inhibit cells more effectively. These findings indicate that diosgenin could be an effective compound in managing GC cells in hypoxia conditions [117]. More recent evidence shows that treatment with diosgenin alone causes a dose-dependent decrease in the cell viability and induces significant increases in G0/G1 cell cycle arrest and apoptosis. However, combined treatment often produces a stronger suppressive effect on tumor cellular function compared to therapeutic outcomes achieved with monotherapy. This was proven in an experiment using diosgenin and GSK126 on GC cells because they synergistically may induce even stronger effects on impaired cell proliferation [118].

2.16. Caraway

Carum carvi (caraway) is a plant of the Apiaceae family. In folk medicine, it is used for indigestion, galactagogue, pneumonia, or eczema [39]. The main components of caraway fruit essential oil are d-carvone, limonene, and myrcene. The percentage of these substances in the oil varies depending on the ecotype and the prevailing environmental conditions [40,212].
D-carvone provides various biological effects, such as antiproliferative, antioxidant, antidiabetic, anti-inflammatory, anti-convulsant antimicrobial, fungicidal, antidiabetic, and insecticidal properties [40,41,42]. Studies on the effects of d-carvone on stomach cancer have shown its ability to inhibit cell proliferation, increase ROS production, and induce apoptosis. It induces a dose-dependent loss of mitochondrial membrane potential. In cells treated with d-carvone at a dose of 20 µM, there was loss of cell structure and chromatin condensation, while at a dose of 25 µM, there was damage to nuclei and complete cell rupture [4]. In addition, d-Carvone downregulates the JAK/STAT2 signaling pathway in GC cells and inhibits JAK/STAT3 signaling pathway in GC cells. However, further research is needed to understand the exact role of d-carvone [41].
Another study assessing the impact of caraway (Carum carvi) extracts on the 2, 3, 7, 8-tetrachloro-dibenzo-p-dioxin-dependent gene expression of cytochrome P450 1A1 in the rat H4IIE cells showed its inhibitory effect. At concentrations above 0.13 µM, there was inhibition of EROD activity; higher concentrations (1.3 and 13 µM) caused an approximately 10-fold suppression of enzyme activity. These substances have the potential to reverse TCDD-dependent induction of cytochrome P450 1A1 and inhibit chemo-induced tumor growth, but there is a need for further research in this area [213].
D-limonene presents antioxidant, anti-inflammatory, and anticancer effects. In a study conducted on nude mice with human GC implanted as a result of the use of d-limonene, a decrease in tumor weight and a decrease in the incidence of liver and peritoneal metastases have been observed mainly due to the induction of apoptosis by limonene [119]. In another study on the synergistic effect of limonene with berberine, limonene shows cytotoxic effects in cells in the MGC803, induces apoptosis, has antioxidant effects, and reduces mitochondrial membrane potential (MMP); lower Blc-2 expression increases caspase-3 expression. This effect is stronger when d-limonene with berberine is used simultaneously than when these substances are used separately. Further studies are needed to determine the mechanism of the synergistic effect of the two substances [214].
Nonspecific lipid transfer proteins (nsLTPs) are found in different plants, but due to their large number, their exact role is not known. They participate in the detection, presentation, and modification of lipids and post-translational transfer between membranes in the cytoplasm. Studies on the nsLTPs1 protein extracted from caraway seeds showed its antioxidant, antiproliferative, and inhibitory effects in a dose-dependent manner against MDA-MB231 and MCF-7 breast cancer cells. However, further studies evaluating the effect of cumin nsLTPs1 proteins and obtaining confirmation of the antiproliferative effect in vivo are needed [39].
Caraway in therapeutic doses is well tolerated and shows no toxic effects. Caraway oil is not recommended for patients with liver disease, gallstones, and other biliary diseases (caraway has an inhibitory effect on gallbladder emptying), achlorhydria, and nephritis. Due to limited data, caraway oil is also not recommended for use during pregnancy and lactation [40].

2.17. Clove

Syzygium alternifolium (SA) is part of the Myrtaceaeu family. It is found geographically in the southeastern Ghats [215]. Syzygium alternifolium has various medicinal uses. Its fruits are used to treat stomach aches and ulcers and treat rheumatic pain; its seeds are used as anti-diabetic agents; its leaves are used to treat dry cough and dysentery; and its stem bark is used as an antiseptic. In addition, SA has hypoglycemic and antihyperglycemic effects [45,215].
The main component of clove oil is eugenol. This oil also contains flavonoids, eugenol acetate, β-caryophyllene, α-humulene, and gallic acid [45,121,216].
Babu TM et al. [45] evaluated the efficacy of three flavonoids in inhibiting HER2 on AGS cell lines. They were (1) 5-hydroxy-7,4′-dimethoxy-6,8-di-C-methylflavone (eucalyptin), (2) kaempferol 3-O-β-d-glucopyranoside, and (3) kaempferol 3-O-α-l-rhamnopyranoside. This study showed that compounds 1, 2, and 3 isolated significantly inhibited the proliferation of human GC cells by arresting the G2/M phase of the cell cycle. Due to the significant activity in the in silico approach in terms of binding affinity to HER2 of substance 2, three new flavonoid analogs for compound 2 from the ZINC database were also checked, namely ZINC67903192, ZINC59763389, and ZINC85816423. These substances have more H-bond acceptor/donor characteristics than compound 2, which improved specificity and selectivity with high binding affinity toward HER2. These studies point to the possibility of developing HER2 inhibitors from natural sources in the future [45].
Clove’s preventive effect on GC is related, among other things, to its antibacterial activity against H. pylori. In addition to its antibacterial activity, eugenol essential oil (EEO) exhibits anti-inflammatory effects. There was no development of resistance against EEO, and it showed activity against biofilm at concentrations of 25 µg/mL and 50 µg/mL against various strains of H. pylori, with suppression percentages of 49.32% and 73.21%, respectively [46]. The braking zone varied according to the study, ranging from 10 ± 06 to 22 ± 04 mm [46,47,48].
Oral rinses with clove extract have a bacteriostatic effect on H. pylori. This action promotes a reduction in the spread of the pathogen and the recurrence of the infection. The efficacy varies depending on the bacterial strain (highest efficacy against slow-growing strains). In addition to growth inhibition, a decrease in CagA expression in H. pylori was also achieved. A limitation may be the risk of potential allergenic effects of rinses containing essential oils [217].
Various animal studies indicate that eugenol has gastroprotective effects. It reduced the severity of lesions and ulcers caused by ethanol and increased the production of gastric mucus without affecting gastric secretion [218,219]. Another study found that eugenol treatment of ethanol-induced ulcers decreased plasma levels of NO, TNF-α, and IL-6 and increased PGE2. Additionally, eugenol showed significant transcriptional and translational upregulations of HSP70 and a downregulation of iNOS in rat gastric tissue [220]. Eugenol has poor bioavailability due to its lipophilic nature. To increase its bioavailability, it is used eugenol nano-formulations like liposomes, nanoparticles, microemulsions, and micelles [221]. It is not toxic. The maximum tolerated dose for humans is 1024 (mg/kg/day). It is well absorbed in the gastrointestinal tract and is almost completely excreted in the urine. Due to its short half-life and rapid metabolism, there is a malevolent risk of accumulation [222].

2.18. Dill

Anethum graveolens (dill) is an herb of the family Apiaceae, which is widely used for both culinary and medicinal purposes. It is used to relieve various ailments such as digestive disorders, soothe stomach irritation, lower lipid and glucose levels, and stimulate lactation. In addition, it exhibits anti-inflammatory, antioxidant, anticancer, and antimicrobial effects [223].
Dill is rich in a variety of substances, such as phenols, flavonoids, tannins, spronines, terpenes, and cardiac glycosides. The main constituents of dill seed essential oil are carvone and d-limonene [49]. There is a lack of current research evaluating the effect of dill extracts on the treatment of GC. Available studies describe its antioxidant and antiradical, anti-glycation effects [50,51]. In a study on mice, A. graveolens seed extracts show effective antisecretory and anti-ulcer effects against HCl and ethanol-induced gastric lesions. This effect may be related to the presence of terpenes and flavonoids; however, further research is needed to determine the exact mechanism of action of dill seeds [52].
Dill can be used in the prevention of GC due to its antimicrobial activity against H. pylori, an infection which is a risk factor for the development of GC. Thanks to its bacteriostatic effect, it can complement currently used therapies [224].
Dill is “generally recognized as safe” (GRAS) as a food by the U.S. Food and Drug Administration. It is generally well tolerated, although occasional allergic skin reactions have been reported, especially after contact with fresh dill. In two studies, nursing mothers were administered d-carvone. No adverse effects were observed in mothers or infants [225]. A. graveolens compounds show good gastrointestinal absorption, lipophilicity, and bioavailability (0.55–0.58). α-pinene, β-pinene, and limonene inhibit four isoenzymes of cytochrome P450 (CYP2C9), while ρ-cymene and meta-cymene inhibit four isoenzymes of cytochrome P450 (CYP2D6) [226].

2.19. Thyme

The Thymus genus, which belongs to the Lamiaceae family, has 350 species, including T. vulgaris, T. serpyllum, T. capitatus, T. sipyleus, and T. schimperi [227]. Thymus vulgaris is a source of many biologically active compounds such as phenols, tannins, glycosides, and flavonoids. The main acts of T. vulgaris are thymol, p-cymene, eugenol, and γ-terpinene. Other compounds present in thyme are carvacolic acid, chlorogenic acid, caffeic acid, benzoic acid, synapinic acid, gallic acid, kemferol, myricetin, and quercetin [53,54].
Thymol exhibits genotoxic and cytotoxic effects on AGS cells in a dose-dependent manner [54,55]. It induces apoptosis by producing ROS (more than a three-fold increase) in various cancer cells and regulates the cell cycle by prolonging the sub-G1 cellular phase in AGS cells. In addition, thymol damages MMPs and activates proapoptotic proteins, Bax, PARP, and caspase-7, -8, and -9. No significant changes were observed in the expression of Bcl-2 [54]. Another study found a decrease in Bcl-2 in a dose-dependent manner and an additional increase in caspase-3 [55]. Another compound contained in thyme is chlorogenic acid, which shows an affinity for GC target genes. In addition, it shows strong anticancer activity against various cancer and non-cancer cell lines (it is active against embryonic lung fibroblasts). It meets all five Lipinski rules and has good lipophilicity and water solubility characteristics [53].
Swiss ADME analysis showed that thymol, carvacrol, p-cymene, and eugenol had good water solubility. These compounds showed high absorption in the gastrointestinal tract with low glycoprotein permeability and no inhibitory effect on CYP2C19 and CYP2C9. The results showed that ethyl acetate and n-butanol fractions of T. vulgaris were safe for oral administration at 800 mL/kg body weight and showed no signs of toxicity. In rats with ethyl acetate- and n-butanol-induced hepatotoxicity, slight decreases in ALT, AST, and ALP activities were observed. If present, ROS-induced hepatotoxicity can be effectively controlled by administering agents that exhibit antioxidant, free radical scavenging, and lipid antioxidant activity [53]. In the case of thymol, there are reports of induction of chromosome number abnormalities when used at the highest concentrations. In vivo studies are needed to confirm whether lower doses will be better tolerated by healthy cells while maintaining efficacy against cancer cells [55].

2.20. Piper Sarmentosum

Piper sarmentosum is an herb about 20 cm tall found in India, Malaysia, Thailand, as well as China. It is a traditional medicinal plant used to treat cough, fever, stomachache, and toothache. Modern research shows that PS has antibacterial, insecticidal, hypoglycemic, anticancer, and hypotensive effects. The main constituents are volatile oil and alkaloids. In addition, it contains small amounts of sterols and lignans [228].
The study from 2023 tested the protective effect of methanolic extract of Piper sarmentosum on gastric mucosal damage as an alternative to other antioxidants. On a group of test rats, Piper sarmentosum supplementation significantly reduced the results of gastric lesions and, interestingly, proved more effective than omeprazole. This study shows that oral Piper sarmentosum supplementation supports protection against the occurrence of gastric lesions, so it is a potential therapeutic agent for gastric ulcers [56]. Unfortunately, studies to date do not describe a direct effect of Piper sarmentosum on gastric cancer. In addition to those mentioned above, additional effects of Piper sarmentosum have been noted. These include promoting fracture healing, neuroprotective, antidepressant, and anti-atherosclerotic effects. However, conclusive data on its safety are lacking [228].

2.21. Basil

Basil is a medicinal herb native to subtropical regions of Asia, Africa, and Central and South America. Essential oils of basil include linalool, estragole, methyl cinnamate, 1,8-cyneol, methylchavicol, eugenol, bergamotene, α-cardinol, limonene, geraniol, and camphor. The anticancer activity of basil extract has been proven [122].
Anticancer effects of basil have been described based on mechanisms such as cell death and the inhibition of cell viability, cytotoxicity, antioxidant activity, apoptosis, reduced tumor growth, and cell cycle arrest. In the case of human GC, Ocimum basilicum leaf extract proved less toxic to tumor cells than Impatiens walleriana, which was tested at the same time. However, cytotoxic effects did occur. This can be attributed to the anthocyanin and flavonoid derivatives present in the extracts [122].

3. Conclusions

Commonly used herbs and spices contain substances with antineoplastic properties (e.g., saffron, black pepper, rosemary, cinnamon). Many of them (e.g., turmeric, ginger, garlic, black pepper, galangal, wasabi) also show anti-inflammatory and immunomodulatory effects. Further, some spices (black cumin, coriander, cardamon) can influence important risk factors for GC, such as H. pylori infection. The effect of chili peppers and other capsaicin-containing plants on GC remains controversial. Future research should focus on the use of not only spices and herbs in the prevention and therapy of GC but also the direct use of compounds in these plants.

Author Contributions

Conceptualization, A.F. and J.B. (Jacek Baj); formal analysis, A.F. and J.B. (Jacek Baj); investigation, K.K., Ł.B., O.K., J.M., A.M., J.B. (Jan Biłogras) and F.W.; data curation, K.K., Ł.B., O.K., J.M., A.M., J.B. (Jan Biłogras) and F.W.; writing—original draft preparation, K.K., Ł.B., O.K., J.M., A.M., J.B. (Jan Biłogras) and F.W.; writing—review and editing, A.F. and J.B. (Jacek Baj); visualization, A.F.; supervision, J.B. (Jacek Baj). All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

5-FU5-fluorouracil
6-MITC6-(methylsulfinyl)hexyl isothiocyanate
ACCAcetyl CoA synthase
AGSGastric adenocarcinoma
AITCAllyl isothiocyanate
AKTProtein kinase B
AktSerine/threonine-protein kinase
ALPAlkaline phosphatise;
AMPKAMP-activated protein kinase
AP-1Activator protein 1
ARFAlternative reading frame
ARFReading frame
ATF1Activating transcription factor 1
[B(a)P]benzo(a)pyrene
BaxBcl2-associated X protein
Bcl-2B-cell lymphoma 2
BUNSerum urea nitrogen
CACinnamaldehyde;
CagACytotoxic-associated gene A
CasNPsCasein nanoparticles
CASP1Caspase-1
CASP3Caspase 3
CASP8Caspase 8
CASP9Caspase 9
CDH1Cadherin 1
CYR61Cysteine-rich angiogenic inducer 61
EBVEpstein–Barr virus
EBVaGCEBV-associated gastric cancer
EOEssential oil
ERK 1/2Extracellular signal-regulated kinase 1/2
FASNFatty acid synthase
Foxm1Forkhead box protein M1
GCGastric cancer
GCSCsGastric cancer stem cells
Gli1GLI Family Zinc Finger 1
GSDMDGasdermin D
GSDMEGasdermin E
GSHGlutathione
GSTGlutathione-S-transferases
GSTPGlutathione S-transferase P
HATsHistone acetyltransferases
HDACsHistone deacetylases
HER2Human epidermal growth factor receptor 2
HIF-1αHypoxia-inducible factor 1-alpha
HMGCR3-hydroxy-3-methylglutaryl-coenzyme A reductase
IFN-γInterferon gamma
ILInterleukin
IL-1βInterleukin-1β
IL-6Interleukin-6
IL-8Interleukin-8
IPIntraperitoneal
JNKC-Jun N-terminal kinases
KIF2CKinesin superfamily member 2C
KLF5Krueppel-like factor 5
LC3 BLight chain 3 B
LDHLactate dehydrogenase
MAPKMitogen-activated protein kinase
MESP1Mesoderm posterior 1
mirMicroRNA
MMPMitochondrial membrane potential
MMP-2Matrix metalloproteinase-2
MMP-9Matrix metalloproteinase-9
MNNGMethyl-N-Nitro-N-Nitrosoguanidine
MyD88Myeloid differentiation primary response 88
MYL9Myosin regulatory light polypeptide 9
NCCN-carboxymethyl chitosan
NCC-SLNCurcumin-loaded modified solid lipid nanoparticles
NF-κBNuclear factor kappa B
NLRP3NLR family pyrin domain containing 3
Nrf2Nuclear factor erythroid 2-related factor 2
NSAIDsNon-steroidal anti-inflammatory drugs
nsLTPsNonspecific lipid transfer proteins
OxROxaliplatin-resistant
P-gpP-glycoprotein
p-JAK2/JAK2Janus associated kinase
p38 MAPKp38 mitogen-activated protein kinases
PARPPoly adenosine diphosphate-ribose polymerase
PCNAProliferating cell nuclear antigen
PDL-1Programmed death-ligand 1
PI3KPhosphatidylinositol-3 kinase
PI3K/Akt/mTORphosphatidylinositol-4,5-bisphosphate 3 kinase/protein kinase B/mechanistic target of rapamycin
PIK3R3Phosphoinositide-3-kinase regulatory subunit 3
PIPPiperine
PKM2Pyruvate kinase muscle isozyme M2
PTTpartial thromboplastin time
ROSReactive oxygen species
RSK/CREBribosomal S6 kinase/cAMP response element binding protein
RSK2ribosomal S6 kinase 2
SAESaffron aqueous extract
SFNSulforaphane
ShhSonic hedgehog homolog
shRNASpecific short hairpin RNA
SMYD3SET and MYN-domain containing 3
SN-387-ethyl 10-hydroxy camptothecin
SPREPB1Sterol regulatory element-binding protein
STAT2Signal transducer and activator of transcription 2
STAT3Signal transducer and activator of transcription 3
TBX15T-box transcription factor 15
TGF-βTransforming growth factor beta
TIMP1Tissue inhibitor of metalloproteinases
TLRsToll-like receptors
TNFTumor necrosis factor
TNF-αTumor necrosis factor α
TP53Tumor suppressor protein p53 gene
TPM4Tropomyosin 4
Uch-L1Ubiquitin carboxy-terminal hydrolase isozyme L1
uPAUrokinase plasminogen activator
uPARuPA receptor
VacAVacuolating cytotoxin A
VEGFVascular Endothelial Growth Factor

References

  1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed]
  2. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69–90. [Google Scholar] [CrossRef] [PubMed]
  3. Lin, C.; Rahaman, A.; Singh, R.; Hui, Y.; Tu, C.; Liu, D.; Zhang, H.; Gong, X. Risk factors for gastric cancer: A comprehensive analysis of observational studies. Front. Public Health 2023, 10, 892468. [Google Scholar]
  4. Correa, P. Gastric Cancer. Overview. Gastroenterol. Clin. N. Am. 2013, 42, 211–217. [Google Scholar] [CrossRef] [PubMed]
  5. Yu, B.; Xiang, L.; Peppelenbosch, M.P.; Fuhler, G.M. Overlapping cytokines in H. pylori infection and gastric cancer: A tandem meta-analysis. Front. Immunol. 2023, 14, 1125658. [Google Scholar] [CrossRef] [PubMed]
  6. Schneider, B.G.; Peng, D.F.; Camargo, M.C.; Piazuelo, M.B.; Sicinschi, L.A.; Mera, R.; Romero-Gallo, J.; Delgado, A.G.; Bravo, L.E.; Wilson, K.T.; et al. Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int. J. Cancer 2010, 127, 2588–2597. [Google Scholar] [CrossRef]
  7. Hatakeyama, M. Helicobacter pylori and gastric carcinogenesis. J. Gastroenterol. 2009, 44, 239–248. [Google Scholar] [CrossRef] [PubMed]
  8. Cover, T.L.; Blanke, S.R. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 2005, 3, 320–332. [Google Scholar] [CrossRef]
  9. Lima, Á.; Sousa, H.; Medeiros, R.; Nobre, A.; Machado, M. PD-L1 expression in EBV associated gastric cancer: A systematic review and meta-analysis. Discov. Oncol. 2022, 13, 19. [Google Scholar] [CrossRef]
  10. Machlowska, J.; Baj, J.; Sitarz, M.; Maciejewski, R.; Sitarz, R. Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int. J. Mol. Sci. 2020, 21, 4012. [Google Scholar] [CrossRef]
  11. Yusefi, A.R.; Lankarani, K.B.; Bastani, P.; Radinmanesh, M.; Kavosi, Z. Risk factors for gastric cancer: A systematic review. Asian Pac. J. Cancer Prev. 2018, 19, 591–603. [Google Scholar] [PubMed]
  12. Joshi, S.S.; Badgwell, B.D. Current treatment and recent progress in gastric cancer. CA Cancer J. Clin. 2021, 71, 264–279. [Google Scholar] [CrossRef] [PubMed]
  13. Bornschein, J.; Rokkas, T.; Selgrad, M.; Malfertheiner, P. Gastric Cancer: Clinical Aspects, Epidemiology and Molecular Background Clinical Management-New Aspects Staging. Helicobacter 2011, 16, 45–52. [Google Scholar] [CrossRef] [PubMed]
  14. Guan, W.L.; He, Y.; Xu, R.H. Gastric cancer treatment: Recent progress and future perspectives. J. Hematol. Oncol. 2023, 16, 57. [Google Scholar] [CrossRef] [PubMed]
  15. Selgrad, M.; Bornschein, J.; Rokkas, T.; Malfertheiner, P. Clinical Aspects of Gastric Cancer and Helicobacter pylori—Screening, Prevention, and Treatment. Helicobacter 2010, 15, 40–45. [Google Scholar] [CrossRef] [PubMed]
  16. Zhang, W.; Cui, N.; Ye, J.; Yang, B.; Sun, Y.; Kuang, H. Curcumin’s prevention of inflammation-driven early gastric cancer and its molecular mechanism. Chin. Herb. Med. 2022, 14, 244–253. [Google Scholar] [CrossRef] [PubMed]
  17. Kwiecien, S.; Magierowski, M.; Majka, J.; Ptak-Belowska, A.; Wojcik, D.; Sliwowski, Z.; Magierowska, K.; Brzozowski, T. Curcumin: A Potent Protectant against Esophageal and Gastric Disorders. Int. J. Mol. Sci. 2019, 20, 1477. [Google Scholar] [CrossRef] [PubMed]
  18. Mohammadi, A.; Khanbabaei, H.; Zandi, F.; Ahmadi, A.; Haftcheshmeh, S.M.; Johnston, T.P.; Sahebkar, A. Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases. Microb. Pathog. 2022, 166, 105552. [Google Scholar] [CrossRef] [PubMed]
  19. Sarkar, A.; De, R.; Mukhopadhyay, A.K. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases. World J. Gastroenterol. 2016, 22, 2736–2748. [Google Scholar] [CrossRef]
  20. Song, M.-Y.; Lee, D.-Y.; Park, S.-Y.; Seo, S.-A.; Hwang, J.-S.; Heo, S.-H.; Kim, E.-H. Steamed Ginger Extract Exerts Anti-inflammatory Effects in Helicobacter pylori-infected Gastric Epithelial Cells through Inhibition of NF-κB. J. Cancer Prev. 2021, 26, 289. [Google Scholar] [CrossRef]
  21. Gaus, K.; Huang, Y.; Israel, D.A.; Pendland, S.L.; Adeniyi, B.A.; Mahady, G.B. Standardized ginger (Zingiber officinale) extract reduces bacterial load and suppresses acute and chronic inflammation in Mongolian gerbils infected with cagA+ Helicobacter pylori. Pharm. Biol. 2009, 47, 92–98. [Google Scholar] [CrossRef] [PubMed]
  22. Sathianarayanan, S.; Ammanath, A.V.; Biswas, R.; B, A.; Sukumaran, S.; Venkidasamy, B. A new approach against Helicobacter pylori using plants and its constituents: A review study. Microb. Pathog. 2022, 168, 105594. [Google Scholar] [CrossRef] [PubMed]
  23. Kodali, R.T.; Eslick, G.D. Meta-analysis: Does garlic intake reduce risk of gastric cancer? Nutr. Cancer 2015, 67, 1–11. [Google Scholar] [CrossRef] [PubMed]
  24. Kim, H.; Keum, N.N.; Giovannucci, E.L.; Fuchs, C.S.; Bao, Y. Garlic intake and gastric cancer risk: Results from two large prospective US cohort studies. Int. J. Cancer 2018, 143, 1047–1053. [Google Scholar] [CrossRef] [PubMed]
  25. Salem, E.M.; Yar, T.; Bamosa, A.O.; Al-Quorain, A.; Yasawy, M.I.; Alsulaiman, R.M.; Randhawa, M.A. Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Saudi J. Gastroenterol. 2010, 16, 207–214. [Google Scholar] [CrossRef] [PubMed]
  26. Hashem-Dabaghian, F.; Agah, S.; Taghavi-Shirazi, M.; Ghobadi, A. Combination of Nigella sativa and Honey in Eradication of Gastric Helicobacter pylori Infection. Iran. Red Crescent Med. J. 2016, 18, e23771. [Google Scholar] [CrossRef]
  27. Toyoda, T.; Shi, L.; Takasu, S.; Cho, Y.M.; Kiriyama, Y.; Nishikawa, A.; Ogawa, K.; Tatematsu, M.; Tsukamoto, T. Anti-Inflammatory Effects of Capsaicin and Piperine on Helicobacter pylori-Induced Chronic Gastritis in Mongolian Gerbils. Helicobacter 2016, 21, 131–142. [Google Scholar] [CrossRef] [PubMed]
  28. Tharmalingam, N.; Kim, S.-H.; Park, M.; Woo, H.J.; Kim, H.W.; Yang, J.Y.; Rhee, K.-J.; Kim, J.B. Inhibitory effect of piperine on Helicobacter pylori growth and adhesion to gastric adenocarcinoma cells. Infect. Agent. Cancer 2014, 9, 43. [Google Scholar] [CrossRef] [PubMed]
  29. Tharmalingam, N.; Park, M.; Lee, M.H.; Woo, H.J.; Kim, H.W.; Yang, J.Y.; Rhee, K.J.; Kim, J.B. Piperine treatment suppresses Helicobacter pylori toxin entry in to gastric epithelium and minimizes β-catenin mediated oncogenesis and IL-8 secretion in vitro. Am. J. Transl. Res. 2016, 8, 885. [Google Scholar]
  30. Wu, B.; Xu, C.; Ding, H.S.; Qiu, L.; Gao, J.X.; Li, M.; Xiong, Y.; Xia, H.; Liu, X. Galangin inhibits neointima formation induced by vascular injury via regulating the PI3K/AKT/mTOR pathway. Food Funct. 2022, 13, 12077–12092. [Google Scholar] [CrossRef]
  31. Wang, D.; Chen, J.; Pu, L.; Yu, L.; Xiong, F.; Sun, L.; Yu, Q.; Cao, X.; Chen, Y.; Peng, F.; et al. Galangin: A food-derived flavonoid with therapeutic potential against a wide spectrum of diseases. Phytother. Res. 2023, 37, 5700–5723. [Google Scholar] [CrossRef] [PubMed]
  32. Kim, D.A.; Jeon, Y.K.; Nam, M.J. Galangin induces apoptosis in gastric cancer cells via regulation of ubiquitin carboxy-terminal hydrolase isozyme L1 and glutathione S-transferase P. Food Chem. Toxicol. 2012, 50, 684–688. [Google Scholar] [CrossRef]
  33. Zaidi, S.F.; Muhammad, J.S.; Shahryar, S.; Usmanghani, K.; Gilani, A.H.; Jafri, W.; Sugiyama, T. Anti-inflammatory and cytoprotective effects of selected Pakistani medicinal plants in Helicobacter pylori-infected gastric epithelial cells. J. Ethnopharmacol. 2012, 141, 403–410. [Google Scholar] [CrossRef]
  34. Skiba, M.A.; Szendzielorz, K.; Mazur, B.; Król, W. The inhibitory effect of flavonoids on interleukin-8 release by human gastric adenocarcinoma (AGS) cells infected with cag PAI (+) Helicobacter pylori. Cent. J. Immunol. 2016, 41, 229–235. [Google Scholar] [CrossRef] [PubMed]
  35. Wang, L.; Xue, J.; Wei, F.; Zheng, G.; Cheng, M.; Liu, S. Chemopreventive effect of galangin against benzo(a)pyrene-induced stomach tumorigenesis through modulating aryl hydrocarbon receptor in Swiss albino mice. Hum. Exp. Toxicol. 2021, 40, 1434–1444. [Google Scholar] [CrossRef]
  36. Masuda, S.; Masuda, H.; Shimamura, Y.; Sugiyama, C.; Takabayashi, F. Improvement Effects of Wasabi (Wasabia japonica) Leaves and Allyl Isothiocyanate on Stomach Lesions of Mongolian Gerbils Infected with Helicobacter pylori. Nat. Prod. Commun. 2017, 12, 595–598. [Google Scholar] [CrossRef]
  37. Gunes-Bayir, A.; Guler, E.M.; Bilgin, M.G.; Ergun, I.S.; Kocyigit, A.; Dadak, A. Anti-Inflammatory and Antioxidant Effects of Carvacrol on N-Methyl- N’-Nitro- N-Nitrosoguanidine (MNNG) Induced Gastric Carcinogenesis in Wistar Rats. Nutrients 2022, 14, 2848. [Google Scholar] [CrossRef] [PubMed]
  38. Qiblawi, S.; Dhanarasu, S.; Faris, M.A.I. Chemopreventive Effect of Cardamom (Elettaria cardamomum L.) Against Benzo(α)Pyrene-Induced Forestomach Papillomagenesis in Swiss Albino Mice. J. Environ. Pathol. Toxicol. Oncol. 2015, 34, 95–104. [Google Scholar] [CrossRef]
  39. Aldakhil, T.; Alshammari, S.O.; Siraj, B.; El-Aarag, B.; Zarina, S.; Salehi, D.; Ahmed, A. The structural characterization and bioactivity assessment of nonspecific lipid transfer protein 1 (nsLTP1) from caraway (Carum carvi) seeds. BMC Complement. Med. Ther. 2023, 23, 254. [Google Scholar] [CrossRef]
  40. Mahboubi, M. Caraway as Important Medicinal Plants in Management of Diseases. Nat. Prod. Bioprospect. 2019, 9, 1–11. [Google Scholar] [CrossRef]
  41. Lv, L.; Yang, N.; Cao, Y.; Dang, J.; Cheng, L.; El-Sheikh, M.A.; Zhang, Y. d-Carvone inhibits the JAK/STAT3 signaling pathway and induced the apoptotic cell death in the human gastric cancer AGS cells. J. Biochem. Mol. Toxicol. 2021, 35, e22746. [Google Scholar] [CrossRef]
  42. Kaefer, C.M.; Milner, J.A. Herbs and Spices in Cancer Prevention and Treatment. In Herbal Medicine: Biomolecular and Clinical Aspects, 2nd ed.; CRC Press: Boca Raton, FL, USA, 2012; pp. 361–382. [Google Scholar] [CrossRef]
  43. Zheng, J.; Zhou, Y.; Li, Y.; Xu, D.P.; Li, S.; Li, H. Bin Spices for Prevention and Treatment of Cancers. Nutrients 2016, 8, 495. [Google Scholar] [CrossRef]
  44. Karimi, A.; Moradi, M.T.; Hashemi, L.; Alidadi, S.; Soltani, A. In vitro anti-proliferative activity of clove extract on human gastric carcinoma. Res. J. Pharmacogn. 2017, 4, 41–48. [Google Scholar]
  45. Babu, T.M.C.; Rammohan, A.; Baki, V.B.; Devi, S.; Gunasekar, D.; Rajendra, W. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of Syzygium alternifolium through molecular dynamics and pharmacophore-based screening. Drug Des. Dev. Ther. 2016, 10, 3611. [Google Scholar] [CrossRef]
  46. Elbestawy, M.K.M.; El-Sherbiny, G.M.; Moghannem, S.A. Antibacterial, Antibiofilm and Anti-Inflammatory Activities of Eugenol Clove Essential Oil against Resistant Helicobacter pylori. Molecules 2023, 28, 2448. [Google Scholar] [CrossRef]
  47. Panezai, S.; Samad, A.; Naeem, M.; Ali, H.; Sadiq, M.B.; Achakzai, M.S.; Kakar, Z.; Akbar, A. Antibacterial Effects of Cinnamon Extract, Clove Oil and Antibiotics against Helicobacter pylori Isolated from Stomach Biopsies. Braz. Arch. Biol. Technol. 2021, 64, e21210089. [Google Scholar] [CrossRef]
  48. El-Shouny, W.A.; Ali, S.S.; Hegazy, H.M.; Abd Elnabi, M.K.; Ali, A.; Sun, J. Syzygium aromaticum L.: Traditional herbal medicine against cagA and vacA toxin genes-producing drug resistant Helicobacter pylori. J. Tradit. Complement. Med. 2020, 10, 366–377. [Google Scholar] [CrossRef]
  49. Caglak, E.; Karsli, B. Use of dill extracts as a natural preservative on shelf-life extension of rainbow trout croquettes during refrigerator storage. Food Sci. Nutr. 2023, 11, 7330–7340. [Google Scholar] [CrossRef]
  50. Oshaghi, E.A.; Khodadadi, I.; Tavilani, H.; Goodarzi, M.T. Aqueous Extract of Anethum graveolens L. has Potential Antioxidant and Antiglycation Effects. Iran. J. Med. Sci. 2016, 41, 328. [Google Scholar] [PubMed]
  51. Li, Z.; Xue, Y.; Li, M.; Guo, Q.; Sang, Y.; Wang, C.; Luo, C. The Antioxidation of Different Fractions of Dill (Anethum graveolens) and Their Influences on Cytokines in Macrophages RAW264.7. J. Oleo Sci 2018, 67, 1535–1541. [Google Scholar] [CrossRef] [PubMed]
  52. Hosseinzadeh, H.; Karimi, G.R.; Ameri, M. Effects of Anethum graveolens L. seed extracts on experimental gastric irritation models in mice. BMC Pharmacol. 2002, 2, 21. [Google Scholar] [CrossRef]
  53. Günes-Bayir, A.; Kiziltan, H.S.; Kocyigit, A.; Güler, E.M.; Karataş, E.; Toprak, A. Effects of natural phenolic compound carvacrol on the human gastric adenocarcinoma (AGS) cells in vitro. Anticancer Drugs 2017, 28, 522–530. [Google Scholar] [CrossRef] [PubMed]
  54. Kang, S.-H.; Kim, Y.-S.; Kim, E.-K.; Hwang, J.-W.; Jeong, J.-H.; Dong, X.; Lee, J.-W.; Moon, S.-H.; Jeon, B.-T.; Park, P.-J. Anticancer Effect of Thymol on AGS Human Gastric Carcinoma Cells. J. Microbiol. Biotechnol. 2016, 26, 28–37. [Google Scholar] [CrossRef] [PubMed]
  55. Saleem, A.; Afzal, M.; Naveed, M.; Makhdoom, S.I.; Mazhar, M.; Aziz, T.; Khan, A.A.; Kamal, Z.; Shahzad, M.; Alharbi, M.; et al. HPLC, FTIR and GC-MS Analyses of Thymus vulgaris Phytochemicals Executing In Vitro and In Vivo Biological Activities and Effects on COX-1, COX-2 and Gastric Cancer Genes Computationally. Molecules 2022, 27, 8512. [Google Scholar] [CrossRef] [PubMed]
  56. Akmal, M.N.; Abdel Aziz, I.; Nur Azlina, M.F. Piper sarmentosum Roxb. methanolic extract prevents stress-induced gastric ulcer by modulating oxidative stress and inflammation. Front. Pharmacol. 2023, 13, 971443. [Google Scholar] [CrossRef] [PubMed]
  57. Zhang, X.; Zhang, C.; Ren, Z.; Zhang, F.; Xu, J.; Zhang, X.; Zheng, H. Curcumin Affects Gastric Cancer Cell Migration, Invasion and Cytoskeletal Remodeling Through Gli1-β-Catenin. Cancer Manag. Res. 2020, 12, 3795–3806. [Google Scholar] [CrossRef] [PubMed]
  58. Fu, H.; Wang, C.; Yang, D.; Wei, Z.; Xu, J.; Hu, Z.; Zhang, Y.; Wang, W.; Yan, R.; Cai, Q. Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling. J. Cell. Physiol. 2018, 233, 4634–4642. [Google Scholar] [CrossRef] [PubMed]
  59. Calcagno, D.Q.; Wisnieski, F.; Da Silva Mota, E.R.; Maia De Sousa, S.B.; Costa Da Silva, J.M.; Leal, M.F.; Gigek, C.O.; Santos, L.C.; Rasmussen, L.T.; Assumpção, P.P.; et al. Role of histone acetylation in gastric cancer: Implications of dietetic compounds and clinical perspectives. Epigenomics 2019, 11, 349–362. [Google Scholar] [CrossRef] [PubMed]
  60. Cao, W.; Fan, R.; Wang, L.; Cheng, S.; Li, H.; Jiang, J.; Geng, M.; Jin, Y.; Wu, Y. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells. Tumour Biol. 2013, 34, 963–971. [Google Scholar] [CrossRef]
  61. Sun, C.; Zhang, S.; Liu, C.; Liu, X. Curcumin Promoted miR-34a Expression and Suppressed Proliferation of Gastric Cancer Cells. Cancer Biother. Radiopharm. 2019, 34, 634–641. [Google Scholar] [CrossRef]
  62. Sun, Q.; Zhang, W.; Guo, Y.; Li, Z.; Chen, X.; Wang, Y.; Du, Y.; Zang, W.; Zhao, G. Curcumin inhibits cell growth and induces cell apoptosis through upregulation of miR-33b in gastric cancer. Tumour Biol. 2016, 37, 13177–13184. [Google Scholar] [CrossRef] [PubMed]
  63. Liu, W.; Huang, M.; Zou, Q.; Lin, W. Curcumin suppresses gastric cancer biological activity by regulation of miRNA-21: An in vitro study. Int. J. Clin. Exp. Pathol. 2018, 11, 5820. [Google Scholar]
  64. Luo, Y.; Chen, X.; Luo, L.; Zhang, Q.; Gao, C.; Zhuang, X.; Yuan, S.; Qiao, T. [6]-Gingerol enhances the radiosensitivity of gastric cancer via G2/M phase arrest and apoptosis induction. Oncol. Rep. 2018, 39, 2252–2260. [Google Scholar] [CrossRef] [PubMed]
  65. Luo, Y.; Zha, L.; Luo, L.; Chen, X.; Zhang, Q.; Gao, C.; Zhuang, X.; Yuan, S.; Qiao, T. [6]-Gingerol enhances the cisplatin sensitivity of gastric cancer cells through inhibition of proliferation and invasion via PI3K/AKT signaling pathway. Phytother. Res. 2019, 33, 1353–1362. [Google Scholar] [CrossRef] [PubMed]
  66. Sharma, S.S.; Gupta, Y.K. Reversal of cisplatin-induced delay in gastric emptying in rats by ginger (Zingiber officinale). J. Ethnopharmacol. 1998, 62, 49–55. [Google Scholar] [CrossRef] [PubMed]
  67. Wang, R.; Lee, Y.G.; Dhandapani, S.; Baek, N.I.; Kim, K.P.; Cho, Y.E.; Xu, X.; Kim, Y.J. 8-paradol from ginger exacerbates PINK1/Parkin mediated mitophagy to induce apoptosis in human gastric adenocarcinoma. Pharmacol. Res. 2023, 187, 106610. [Google Scholar] [CrossRef] [PubMed]
  68. Arreola, R.; Quintero-Fabián, S.; Lopez-Roa, R.I.; Flores-Gutierrez, E.O.; Reyes-Grajeda, J.P.; Carrera-Quintanar, L.; Ortuno-Sahagun, D. Immunomodulation and anti-inflammatory effects of garlic compounds. J. Immunol. Res. 2015, 2015, 401630. [Google Scholar] [CrossRef]
  69. Mondal, A.; Banerjee, S.; Bose, S.; Mazumder, S.; Haber, R.A.; Farzaei, M.H.; Bishayee, A. Garlic constituents for cancer prevention and therapy: From phytochemistry to novel formulations. Pharmacol. Res. 2022, 175, 105837. [Google Scholar] [CrossRef] [PubMed]
  70. Zhang, W.; Ha, M.; Gong, Y.; Xu, Y.; Dong, N.; Yuan, Y. Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways. Oncol. Rep. 2010, 24, 1585–1592. [Google Scholar] [CrossRef] [PubMed]
  71. Zhang, X.; Zhu, Y.; Duan, W.; Feng, C.; He, X. Allicin induces apoptosis of the MGC-803 human gastric carcinoma cell line through the p38 mitogen-activated protein kinase/caspase-3 signaling pathway. Mol. Med. Rep. 2015, 11, 2755–2760. [Google Scholar] [CrossRef]
  72. Ling, H.; Lu, L.F.; He, J.; Xiao, G.H.; Jiang, H.; Su, Q. Diallyl disulfide selectively causes checkpoint kinase-1 mediated G2/M arrest in human MGC803 gastric cancer cell line. Oncol. Rep. 2014, 32, 2274–2282. [Google Scholar] [CrossRef] [PubMed]
  73. Mitra, S.; Das, R.; Emran, T.B.; Labib, R.K.; Noor, E.T.; Islam, F.; Sharma, R.; Ahmad, I.; Nainu, F.; Chidambaram, K.; et al. Diallyl Disulfide: A Bioactive Garlic Compound with Anticancer Potential. Front. Pharmacol. 2022, 13, 943967. [Google Scholar] [CrossRef] [PubMed]
  74. Choi, Y.H. Diallyl trisulfide induces apoptosis and mitotic arrest in AGS human gastric carcinoma cells through reactive oxygen species-mediated activation of AMP-activated protein kinase. Biomed. Pharmacother. 2017, 94, 63–71. [Google Scholar] [CrossRef] [PubMed]
  75. Park, J.M.; Han, Y.M.; Kangwan, N.; Lee, S.Y.; Jung, M.K.; Kim, E.H.; Hahm, K.B. S-allyl cysteine alleviates nonsteroidal anti-inflammatory drug-induced gastric mucosal damages by increasing cyclooxygenase-2 inhibition, heme oxygenase-1 induction, and histone deacetylation inhibition. J. Gastroenterol. Hepatol. 2014, 29 (Suppl. S4), 80–92. [Google Scholar] [CrossRef] [PubMed]
  76. Kangwan, N.; Park, J.M.; Kim, E.H.; Hahm, K.B. Quality of healing of gastric ulcers: Natural products beyond acid suppression. World J. Gastrointest. Pathophysiol. 2014, 5, 40. [Google Scholar] [CrossRef] [PubMed]
  77. Li, W.Q.; Zhang, J.Y.; Ma, J.L.; Li, Z.X.; Zhang, L.; Zhang, Y.; Guo, Y.; Zhou, T.; Li, J.Y.; Shen, L.; et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: Follow-up of a randomized intervention trial. BMJ 2019, 366, l5016. [Google Scholar] [CrossRef] [PubMed]
  78. Guo, Y.; Li, Z.X.; Zhang, J.Y.; Ma, J.L.; Zhang, L.; Zhang, Y.; Zhou, T.; Liu, W.D.; Han, Z.X.; Li, W.Q.; et al. Association Between Lifestyle Factors, Vitamin and Garlic Supplementation, and Gastric Cancer Outcomes: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw. Open 2020, 3, e206628. [Google Scholar] [CrossRef] [PubMed]
  79. Ma, J.L.; Zhang, L.; Brown, L.M.; Li, J.Y.; Shen, L.; Pan, K.F.; Liu, W.D.; Hu, Y.; Han, Z.X.; Crystal-Mansour, S.; et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J. Natl. Cancer Inst. 2012, 104, 488–492. [Google Scholar] [CrossRef] [PubMed]
  80. Feng, L.M.; Wang, X.F.; Huang, Q.X. Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway. J. Biosci. 2017, 42, 547–554. [Google Scholar] [CrossRef]
  81. He, P.; He, Y.; Ma, J.; Liu, Y.; Liu, C.; Baoping, Y.; Dong, W. Thymoquinone induces apoptosis and protective autophagy in gastric cancer cells by inhibiting the PI3K/Akt/mTOR pathway. Phytother. Res. 2023, 37, 3467–3480. [Google Scholar] [CrossRef]
  82. Zhu, W.Q.; Wang, J.; Guo, X.F.; Liu, Z.; Dong, W.G. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro. World J. Gastroenterol. 2016, 22, 4149–4159. [Google Scholar] [CrossRef]
  83. Lei, X.; Lv, X.; Liu, M.; Yang, Z.; Ji, M.; Guo, X.; Dong, W. Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo. Biochem. Biophys. Res. Commun. 2012, 417, 864–868. [Google Scholar] [CrossRef]
  84. Park, S.Y.; Kim, J.Y.; Lee, S.M.; Jun, C.H.; Cho, S.B.; Park, C.H.; Joo, Y.E.; Kim, H.S.; Choi, S.K.; Rew, J.S. Capsaicin induces apoptosis and modulates MAPK signaling in human gastric cancer cells. Mol. Med. Rep. 2014, 9, 499–502. [Google Scholar] [CrossRef]
  85. Wang, F.; Zhao, J.; Liu, D.; Zhao, T.; Lu, Z.; Zhu, L.; Cao, L.; Yang, J.; Jin, J.; Cai, Y. Capsaicin reactivates hMOF in gastric cancer cells and induces cell growth inhibition. Cancer Biol. Ther. 2016, 17, 1117–1125. [Google Scholar] [CrossRef]
  86. Luo, L.; Yan, J.; Wang, X.; Sun, Z. The correlation between chili pepper consumption and gastric cancer risk: A meta-analysis. Asia Pac. J. Clin. Nutr. 2021, 30, 130–139. [Google Scholar] [CrossRef]
  87. López-Carrillo, L.; López-Cervantes, M.; Robles-Díaz, G.; Ramírez-Espitia, A.; Mohar-Betancourt, A.; Meneses-García, A.; López-Vidal, Y.; Blair, A. Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico. Int. J. Cancer 2003, 106, 277–282. [Google Scholar] [CrossRef]
  88. López-carnllo, L.; Avila, M.H.; Dubrow, R. Chili pepper consumption and gastric cancer in Mexico: A case-control study. Am. J. Epidemiol. 1994, 139, 263–271. [Google Scholar] [CrossRef]
  89. Luo, Y.; Yu, P.; Zhao, J.; Guo, Q.; Fan, B.; Diao, Y.; Jin, Y.; Wu, J.; Zhang, C. Inhibitory Effect of Crocin Against Gastric Carcinoma via Regulating TPM4 Gene. Onco-Targets Ther. 2021, 14, 111–122. [Google Scholar] [CrossRef]
  90. Hoshyar, R.; Bathaie, S.Z.; Sadeghizadeh, M. Crocin triggers the apoptosis through increasing the Bax/Bcl-2 ratio and caspase activation in human gastric adenocarcinoma, AGS, cells. DNA Cell Biol. 2013, 32, 50–57. [Google Scholar] [CrossRef]
  91. Bathaie, S.Z.; Hoshyar, R.; Miri, H.; Sadeghizadeh, M. Anticancer effects of crocetin in both human adenocarcinoma gastric cancer cells and rat model of gastric cancer. Biochem. Cell Biol. 2013, 91, 397–403. [Google Scholar] [CrossRef]
  92. Zang, M.; Hou, J.; Huang, Y.; Wang, J.; Ding, X.; Zhang, B.; Wang, Y.; Xuan, Y.; Zhou, Y. Crocetin suppresses angiogenesis and metastasis through inhibiting sonic hedgehog signaling pathway in gastric cancer. Biochem. Biophys. Res. Commun. 2021, 576, 86–92. [Google Scholar] [CrossRef] [PubMed]
  93. Chen, H.; Sheng, H.; Zhao, Y.; Zhu, G. Piperine Inhibits Cell Proliferation and Induces Apoptosis of Human Gastric Cancer Cells by Downregulating Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway. Med. Sci. Monit. 2020, 26, e928403-1. [Google Scholar] [CrossRef] [PubMed]
  94. Xia, Y.; Khoi, P.N.; Yoon, H.J.; Lian, S.; Joo, Y.E.; Chay, K.O.; Kim, K.K.; Jung, Y. Do Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells. Mol. Cell. Biochem. 2015, 398, 147–156. [Google Scholar] [CrossRef]
  95. Wang, L.; Zhang, Y.; Liu, K.; Chen, H.; Yang, R.; Ma, X.; Kim, H.G.; Bode, A.M.; Kim, D.J.; Dong, Z. Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2. Oncotarget 2018, 9, 34200–34212. [Google Scholar] [CrossRef]
  96. Shrestha, S.; Song, Y.W.; Kim, H.; Lee, D.S.; Cho, S.K. Sageone, a diterpene from Rosmarinus officinalis, synergizes with cisplatin cytotoxicity in SNU-1 human gastric cancer cells. Phytomedicine 2016, 23, 1671–1679. [Google Scholar] [CrossRef]
  97. Liang, X.; Wang, P.; Yang, C.; Huang, F.; Wu, H.; Shi, H.; Wu, X. Galangin Inhibits Gastric Cancer Growth Through Enhancing STAT3 Mediated ROS Production. Front. Pharmacol. 2021, 12, 646628. [Google Scholar] [CrossRef]
  98. In Vitro Effects and the Related Molecular Mechanism of Galangin and Quercetin on Human Gastric Cancer Cell Line (SGC-7901)—PubMed. Available online: https://pubmed.ncbi.nlm.nih.gov/29039326/ (accessed on 5 January 2024).
  99. Liang, X.H.; Yu, M.Z.; Shi, H.L.; Wu, X.J. Galangin enhances autophagy by inhibiting NF-κB pathway in gastric cancer MGC-803 cells. Zhongguo Zhong Yao Za Zhi 2021, 46, 4167–4174. [Google Scholar] [CrossRef]
  100. Rong, Y.; Liu, S.H.; Tang, M.Z.; Yang, X.J. Quercetin inhibits the proliferative effect of gastric cancer cells by activating the pyroptosis pathway. Asian J. Surg. 2023, 46, 5286–5288. [Google Scholar] [CrossRef] [PubMed]
  101. Zhao, G.; Xue, S. Mechanism of Quercetin as a Multidrug-resistant Reversing Compound in Oxaliplatin-resistant Gastric-cancer Cell Lines. Altern. Ther. Health Med. 2023, 29, 54–59. [Google Scholar]
  102. Mirazimi, S.M.A.; Dashti, F.; Tobeiha, M.; Shahini, A.; Jafari, R.; Khoddami, M.; Sheida, A.H.; EsnaAshari, P.; Aflatoonian, A.H.; Elikaii, F.; et al. Application of Quercetin in the Treatment of Gastrointestinal Cancers. Front. Pharmacol. 2022, 13, 860209. [Google Scholar] [CrossRef]
  103. Borska, S.; Chmielewska, M.; Wysocka, T.; Drag-Zalesinska, M.; Zabel, M.; Dziegiel, P. In vitro effect of quercetin on human gastric carcinoma: Targeting cancer cells death and MDR. Food Chem. Toxicol. 2012, 50, 3375–3383. [Google Scholar] [CrossRef] [PubMed]
  104. Jiang, K.; Liu, H.; Ge, J.; Yang, B.; Wang, Y.; Wang, W.; Wen, Y.; Zeng, S.; Chen, Q.; Huang, J.; et al. A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis. Heliyon 2023, 9, e19546. [Google Scholar] [CrossRef]
  105. Shen, X.; Si, Y.; Wang, Z.; Wang, J.; Guo, Y.; Zhang, X. Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K/Akt signaling. Int. J. Mol. Med. 2016, 38, 619–626. [Google Scholar] [CrossRef] [PubMed]
  106. Rajakumar, T.; Pugalendhi, P. Allyl isothiocyanate regulates oxidative stress, inflammation, cell proliferation, cell cycle arrest, apoptosis, angiogenesis, invasion and metastasis via interaction with multiple cell signaling pathways. Histochem. Cell Biol. 2023, 161, 211–221. [Google Scholar] [CrossRef] [PubMed]
  107. Lin, T.S.; Huang, W.N.; Yang, J.L.; Peng, S.F.; Liu, K.C.; Chen, J.C.; Hsia, T.C.; Huang, A.C. Allyl isothiocyanate inhibits cell migration and invasion in human gastric cancer AGS cells via affecting PI3K/AKT and MAPK signaling pathway in vitro. Environ. Toxicol. 2023, 38, 2287–2297. [Google Scholar] [CrossRef]
  108. Shih, Y.; Hsu, S.; Lai, K.; Chueh, F.; Huang, Y.; Kuo, C.; Chen, Y.; Chen, C.; Peng, S.; Huang, W.; et al. Allyl isothiocyanate induces DNA damage and inhibits DNA repair-associated proteins in a human gastric cancer cells in vitro. Environ. Toxicol. 2023, 39, 1303–1314. [Google Scholar] [CrossRef] [PubMed]
  109. Zhang, Q.; Cao, W.; Yang, C.; Hong, L.; Geng, S.; Han, H.; Zhong, C. Isothiocyanates attenuate immune checkpoint blockage therapy in gastric cancer via induction of PD-L1 expression. J. Nutr. Biochem. 2023, 112, 109226. [Google Scholar] [CrossRef] [PubMed]
  110. Gu, P.; Wu, L. na Sulforaphane Targets the TBX15/KIF2C Pathway to Repress Glycolysis and Cell Proliferation in Gastric Carcinoma Cells. Nutr. Cancer 2023, 75, 1263–1270. [Google Scholar] [CrossRef]
  111. Peng, Z.T.; Gu, P. Sulforaphane suppresses autophagy during the malignant progression of gastric carcinoma via activating miR-4521/PIK3R3 pathway. Hum. Exp. Toxicol. 2021, 40, S711–S720. [Google Scholar] [CrossRef]
  112. Manikandan, P.; Vinothini, G.; Vidya Priyadarsini, R.; Prathiba, D.; Nagini, S. Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG. Investig. New Drugs 2011, 29, 110–117. [Google Scholar] [CrossRef]
  113. Sarkar, A.; Bhattacharjee, S.; Mandal, D.P. Induction of Apoptosis by Eugenol and Capsaicin in Human Gastric Cancer AGS Cells-Elucidating the Role of p53. Asian Pac. J. Cancer Prev. 2015, 16, 6753–6759. [Google Scholar] [CrossRef] [PubMed]
  114. Kim, T.W. Cinnamaldehyde induces autophagy-mediated cell death through ER stress and epigenetic modification in gastric cancer cells. Acta Pharmacol. Sin. 2022, 43, 712–723. [Google Scholar] [CrossRef] [PubMed]
  115. Balusamy, S.R.; Perumalsamy, H.; Huq, M.A.; Balasubramanian, B. Anti-proliferative activity of Origanum vulgare inhibited lipogenesis and induced mitochondrial mediated apoptosis in human stomach cancer cell lines. Biomed. Pharmacother. 2018, 108, 1835–1844. [Google Scholar] [CrossRef] [PubMed]
  116. Gu, L.; Zheng, H.; Zhao, R.; Zhang, X.; Wang, Q. Diosgenin inhibits the proliferation of gastric cancer cells via inducing mesoderm posterior 1 down-regulation-mediated alternative reading frame expression. Hum. Exp. Toxicol. 2021, 40, S632–S645. [Google Scholar] [CrossRef] [PubMed]
  117. Mao, Z.J.; Tang, Q.J.; Zhang, C.A.; Qin, Z.F.; Pang, B.; Wei, P.K.; Liu, B.; Chou, Y.N. Anti-proliferation and anti-invasion effects of diosgenin on gastric cancer BGC-823 cells with HIF-1α shRNAs. Int. J. Mol. Sci. 2012, 13, 6521–6533. [Google Scholar] [CrossRef]
  118. Liu, S.; Rong, G.; Li, X.; Geng, L.; Zeng, Z.; Jiang, D.; Yang, J.; Wei, Y. Diosgenin and GSK126 Produce Synergistic Effects on Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway. Onco-Targets Ther. 2020, 13, 5057–5067. [Google Scholar] [CrossRef] [PubMed]
  119. Lu, X.G.; Zhan, L.B.; Feng, B.A.; Qu, M.Y.; Yu, L.H.; Xie, J.H. Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene. World J. Gastroenterol. 2004, 10, 2140. [Google Scholar] [CrossRef] [PubMed]
  120. Sarkar, A.; Das, S.; Rahaman, A.; Das Talukdar, A.; Bhattacharjee, S.; Mandal, D.P. Eugenol and capsaicin exhibit anti-metastatic activity via modulating TGF-β signaling in gastric carcinoma. Food Funct. 2020, 11, 9020–9034. [Google Scholar] [CrossRef] [PubMed]
  121. Teixeira, C.; Pereira, R.B.; Pinto, N.F.S.; Coelho, C.M.M.; Fernandes, M.J.G.; Fortes, A.G.; Gonçalves, M.S.T.; Pereira, D.M. Eugenol β-Amino/β-Alkoxy Alcohols with Selective Anticancer Activity. Int. J. Mol. Sci. 2022, 23, 3759. [Google Scholar] [CrossRef]
  122. Perna, S.; Alawadhi, H.; Riva, A.; Allegrini, P.; Petrangolini, G.; Gasparri, C.; Alalwan, T.A.; Rondanelli, M. In Vitro and In Vivo Anticancer Activity of Basil (Ocimum spp.): Current Insights and Future Prospects. Cancers 2022, 14, 2375. [Google Scholar] [CrossRef]
  123. Gao, T.H.; Liao, W.; Lin, L.T.; Zhu, Z.P.; Lu, M.G.; Fu, C.M.; Xie, T. Curcumae rhizoma and its major constituents against hepatobiliary disease: Pharmacotherapeutic properties and potential clinical applications. Phytomedicine 2022, 102, 154090. [Google Scholar] [CrossRef] [PubMed]
  124. Barati, N.; Momtazi-Borojeni, A.A.; Majeed, M.; Sahebkar, A. Potential therapeutic effects of curcumin in gastric cancer. J. Cell. Physiol. 2019, 234, 2317–2328. [Google Scholar] [CrossRef] [PubMed]
  125. Santos, A.M.; Lopes, T.; Oleastro, M.; Gato, I.V.; Floch, P.; Benejat, L.; Chaves, P.; Pereira, T.; Seixas, E.; Machado, J.; et al. Curcumin inhibits gastric inflammation induced by Helicobacter pylori infection in a mouse model. Nutrients 2015, 7, 306–320. [Google Scholar] [CrossRef] [PubMed]
  126. Soleimani, V.; Sahebkar, A.; Hosseinzadeh, H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytother. Res. 2018, 32, 985–995. [Google Scholar] [CrossRef] [PubMed]
  127. Chainani-Wu, N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J. Altern. Complement. Med. 2003, 9, 161–168. [Google Scholar] [CrossRef] [PubMed]
  128. Cas, M.D.; Ghidoni, R. Dietary Curcumin: Correlation between Bioavailability and Health Potential. Nutrients 2019, 11, 2147. [Google Scholar] [CrossRef] [PubMed]
  129. Baek, J.S.; Cho, C.W. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake. Eur. J. Pharm. Biopharm. 2017, 117, 132–140. [Google Scholar] [CrossRef]
  130. Barick, K.C.; Tripathi, A.; Dutta, B.; Shelar, S.B.; Hassan, P.A. Curcumin Encapsulated Casein Nanoparticles: Enhanced Bioavailability and Anticancer Efficacy. J. Pharm. Sci. 2021, 110, 2114–2120. [Google Scholar] [CrossRef] [PubMed]
  131. Feng, T.; Wei, Y.; Lee, R.J.; Zhao, L. Liposomal curcumin and its application in cancer. Int. J. Nanomed. 2017, 12, 6027–6044. [Google Scholar] [CrossRef]
  132. Mohanty, C.; Das, M.; Sahoo, S.K. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opin. Drug Deliv. 2012, 9, 1347–1364. [Google Scholar] [CrossRef]
  133. Zhang, M.; Zhao, R.; Wang, D.; Wang, L.; Zhang, Q.; Wei, S.; Lu, F.; Peng, W.; Wu, C. Ginger (Zingiber officinale Rosc.) and its bioactive components are potential resources for health beneficial agents. Phytother. Res. 2021, 35, 711–742. [Google Scholar] [CrossRef] [PubMed]
  134. Unuofin, J.O.; Masuku, N.P.; Paimo, O.K.; Lebelo, S.L. Ginger from Farmyard to Town: Nutritional and Pharmacological Applications. Front. Pharmacol. 2021, 12, 779352. [Google Scholar] [CrossRef] [PubMed]
  135. Li, Y.; Tran, V.H.; Duke, C.C.; Roufogalis, B.D. Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review. Evid.-Based Complement. Alternat. Med. 2012, 2012, 516870. [Google Scholar] [CrossRef] [PubMed]
  136. Sato, H.; Ogino, M.; Yakushiji, K.; Suzuki, H.; Shiokawa, K.I.; Kikuchi, H.; Seto, Y.; Onoue, S. Ginger Extract-Loaded Solid Dispersion System with Enhanced Oral Absorption and Antihypothermic Action. J. Agric. Food Chem. 2017, 65, 1365–1370. [Google Scholar] [CrossRef] [PubMed]
  137. Londhe, V.Y.; Khogta, S.M.; Barve, K.H. Improved anti-arthritic activity of ginger extract, a traditional medicine, using novel drug delivery approach. J. Complement. Integr. Med. 2020, 18, 439–443. [Google Scholar] [CrossRef] [PubMed]
  138. Hannan, M.A.; Rahman, M.A.; Sohag, A.A.M.; Uddin, M.J.; Dash, R.; Sikder, M.H.; Rahman, M.S.; Timalsina, B.; Munni, Y.A.; Sarker, P.P.; et al. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients 2021, 13, 1784. [Google Scholar] [CrossRef] [PubMed]
  139. Shariare, M.H.; Khan, M.A.; Al-Masum, A.; Khan, J.H.; Uddin, J.; Kazi, M. Development of Stable Liposomal Drug Delivery System of Thymoquinone and Its In Vitro Anticancer Studies Using Breast Cancer and Cervical Cancer Cell Lines. Molecules 2022, 27, 6744. [Google Scholar] [CrossRef] [PubMed]
  140. Khan, S.A.; Khan, A.M.; Karim, S.; Kamal, M.A.; Damanhouri, G.A.; Mirza, Z. Panacea seed “Nigella”: A review focusing on regenerative effects for gastric ailments. Saudi J. Biol. Sci. 2016, 23, 542–553. [Google Scholar] [CrossRef]
  141. Azlan, A.; Sultana, S.; Huei, C.S.; Razman, M.R. Antioxidant, Anti-Obesity, Nutritional and Other Beneficial Effects of Different Chili Pepper: A Review. Molecules 2022, 27, 898. [Google Scholar] [CrossRef]
  142. Chen, C.; Zhang, M.; Zheng, X.; Lang, H. Association between chili pepper consumption and risk of gastrointestinal-tract cancers: A meta-analysis. Front. Nutr. 2022, 9, 935865. [Google Scholar] [CrossRef]
  143. Bley, K.; Boorman, G.; Mohammad, B.; McKenzie, D.; Babbar, S. A comprehensive review of the carcinogenic and anticarcinogenic potential of capsaicin. Toxicol. Pathol. 2012, 40, 847–873. [Google Scholar] [CrossRef] [PubMed]
  144. Merritt, J.C.; Richbart, S.D.; Moles, E.G.; Cox, A.J.; Brown, K.C.; Miles, S.L.; Finch, P.T.; Hess, J.A.; Tirona, M.T.; Valentovic, M.A.; et al. Anti-cancer activity of sustained release capsaicin formulations. Pharmacol. Ther. 2022, 238, 108177. [Google Scholar] [CrossRef] [PubMed]
  145. José Bagur, M.; Alonso Salinas, G.L.; Jiménez-Monreal, A.M.; Chaouqi, S.; Llorens, S.; Martínez-Tomé, M.; Alonso, G.L. Saffron: An Old Medicinal Plant and a Potential Novel Functional Food. Molecules 2017, 23, 30. [Google Scholar] [CrossRef] [PubMed]
  146. Predieri, S.; Magli, M.; Gatti, E.; Camilli, F.; Vignolini, P.; Romani, A. Chemical Composition and Sensory Evaluation of Saffron. Foods 2021, 10, 2604. [Google Scholar] [CrossRef] [PubMed]
  147. Masi, E.; Taiti, C.; Heimler, D.; Vignolini, P.; Romani, A.; Mancuso, S. PTR-TOF-MS and HPLC analysis in the characterization of saffron (Crocus sativus L.) from Italy and Iran. Food Chem. 2016, 192, 75–81. [Google Scholar] [CrossRef] [PubMed]
  148. García-Rodríguez, M.V.; López-Córcoles, H.; Alonso, G.L.; Pappas, C.S.; Polissiou, M.G.; Tarantilis, P.A. Comparative evaluation of an ISO 3632 method and an HPLC-DAD method for safranal quantity determination in saffron. Food Chem. 2017, 221, 838–843. [Google Scholar] [CrossRef] [PubMed]
  149. Vakili, R.; Toroghian, M.; Torshizi, M.E. Saffron extract feed improves the antioxidant status of laying hens and the inhibitory effect on cancer cells (PC3 and MCF7) Growth. Vet. Med. Sci. 2022, 8, 2494–2503. [Google Scholar] [CrossRef] [PubMed]
  150. Bathaie, S.Z.; Miri, H.; Mohagheghi, M.A.; Mokhtari-Dizaji, M.; Shahbazfar, A.A.; Hasanzadeh, H. Saffron Aqueous Extract Inhibits the Chemically-induced Gastric Cancer Progression in the Wistar Albino Rat. Iran. J. Basic Med. Sci. 2013, 16, 27. [Google Scholar]
  151. Wu, Z.; Hui, J. Crocin reverses 1-methyl-3-nitroso-1-nitroguanidine (MNNG)-induced malignant transformation in GES-1 cells through the Nrf2/Hippo signaling pathway. J. Gastrointest. Oncol. 2020, 11, 1242–1252. [Google Scholar] [CrossRef]
  152. Zhou, Y.; Xu, Q.; Shang, J.; Lu, L.; Chen, G. Crocin inhibits the migration, invasion, and epithelial-mesenchymal transition of gastric cancer cells via miR-320/KLF5/HIF-1α signaling. J. Cell. Physiol. 2019, 234, 17876–17885. [Google Scholar] [CrossRef]
  153. Shafiee, M.; Arekhi, S.; Omranzadeh, A.; Sahebkar, A. Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. J. Affect. Disord. 2018, 227, 330–337. [Google Scholar] [CrossRef] [PubMed]
  154. Hosseinzadeh, H.; Shakib, S.S.; Sameni, A.K.; Taghiabadi, E. Acute and Subacute Toxicity of Safranal, a Constituent of Saffron, in Mice and Rats. Iran. J. Pharm. Res. IJPR 2013, 12, 93. [Google Scholar] [CrossRef] [PubMed]
  155. Mohamadpour, A.H.; Ayati, Z.; Parizadeh, M.R.; Rajbai, O.; Hosseinzadeh, H. Safety Evaluation of Crocin (a constituent of saffron) Tablets in Healthy Volunteers. Iran. J. Basic Med. Sci. 2013, 16, 39. [Google Scholar]
  156. Modaghegh, M.H.; Shahabian, M.; Esmaeili, H.A.; Rajbai, O.; Hosseinzadeh, H. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine 2008, 15, 1032–1037. [Google Scholar] [CrossRef] [PubMed]
  157. Takooree, H.; Aumeeruddy, M.Z.; Rengasamy, K.R.R.; Venugopala, K.N.; Jeewon, R.; Zengin, G.; Mahomoodally, M.F. A systematic review on black pepper (Piper nigrum L.): From folk uses to pharmacological applications. Crit. Rev. Food Sci. Nutr. 2019, 59, S210–S243. [Google Scholar] [CrossRef] [PubMed]
  158. Haq, I.U.; Imran, M.; Nadeem, M.; Tufail, T.; Gondal, T.A.; Mubarak, M.S. Piperine: A review of its biological effects. Phytother. Res. 2021, 35, 680–700. [Google Scholar] [CrossRef] [PubMed]
  159. Prashant, A.; Rangaswamy, C.; Yadav, A.; Reddy, V.; Sowmya, M.; Madhunapantula, S. In vitro anticancer activity of ethanolic extracts of Piper nigrum against colorectal carcinoma cell lines. Int. J. Appl. Basic Med. Res. 2017, 7, 67–72. [Google Scholar] [CrossRef]
  160. Lasso, P.; Rojas, L.; Arévalo, C.; Urueña, C.; Murillo, N.; Nossa, P.; Sandoval, T.; Chitiva, L.C.; Barreto, A.; Costa, G.M.; et al. Piper nigrum extract suppresses tumor growth and enhances the antitumor immune response in murine models of breast cancer and melanoma. Cancer Immunol. Immunother. 2023, 72, 3279–3292. [Google Scholar] [CrossRef] [PubMed]
  161. Guo, L.; Yang, Y.; Sheng, Y.J.; Wang, J.; Ruan, S.; Han, C. Mechanism of piperine in affecting apoptosis and proliferation of gastric cancer cells via ROS-mitochondria-associated signalling pathway. J. Cell. Mol. Med. 2021, 25, 9513–9522. [Google Scholar] [CrossRef]
  162. Bastaki, M.; Aubanel, M.; Bauter, M.; Cachet, T.; Demyttenaere, J.; Diop, M.M.; Harman, C.L.; Hayashi, S.m.; Krammer, G.; Li, X.; et al. Absence of adverse effects following administration of piperine in the diet of Sprague-Dawley rats for 90 days. Food Chem. Toxicol. 2018, 120, 213–221. [Google Scholar] [CrossRef]
  163. Thiel, A.; Buskens, C.; Woehrle, T.; Etheve, S.; Schoenmakers, A.; Fehr, M.; Beilstein, P. Black pepper constituent piperine: Genotoxicity studies in vitro and in vivo. Food Chem. Toxicol. 2014, 66, 350–357. [Google Scholar] [CrossRef] [PubMed]
  164. Ziegenhagen, R.; Heimberg, K.; Lampen, A.; Hirsch-Ernst, K.I. Safety Aspects of the Use of Isolated Piperine Ingested as a Bolus. Foods 2021, 10, 2121. [Google Scholar] [CrossRef]
  165. Chinta, G.; Periyasamy, L. Reversible Anti-Spermatogenic Effect of Piperine on Epididymis and Seminal Vesicles of Albino Rats. Drug Res. 2016, 66, 420–426. [Google Scholar] [CrossRef] [PubMed]
  166. Chinta, G.; Coumar, M.S.; Periyasamy, L. Reversible Testicular Toxicity of Piperine on Male Albino Rats. Pharmacogn. Mag. 2017, 13, S525–S532. [Google Scholar] [CrossRef]
  167. Gorgani, L.; Mohammadi, M.; Najafpour, G.D.; Nikzad, M. Piperine-The Bioactive Compound of Black Pepper: From Isolation to Medicinal Formulations. Compr. Rev. Food Sci. Food Saf. 2017, 16, 124–140. [Google Scholar] [CrossRef]
  168. Ganesh Bhat, B.; Chandrasekhara, N. Studies on the metabolism of piperine: Absorption, tissue distribution and excretion of urinary conjugates in rats. Toxicology 1986, 40, 83–92. [Google Scholar] [CrossRef]
  169. Suresh, D.; Srinivasan, K. Studies on the in vitro absorption of spice principles--curcumin, capsaicin and piperine in rat intestines. Food Chem. Toxicol. 2007, 45, 1437–1442. [Google Scholar] [CrossRef]
  170. Allegra, A.; Tonacci, A.; Pioggia, G.; Musolino, C.; Gangemi, S. Anticancer Activity of Rosmarinus officinalis L.: Mechanisms of Action and Therapeutic Potentials. Nutrients 2020, 12, 1739. [Google Scholar] [CrossRef]
  171. Moore, J.; Yousef, M.; Tsiani, E. Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols. Nutrients 2016, 8, 731. [Google Scholar] [CrossRef]
  172. Karimi, N.; Rashedi, J.; Poor, B.M.; Arabi, S.; Ghorbani, M.; Tahmasebpour, N.; Asgharzadeh, M. Cytotoxic effect of rosemary extract on gastric adenocarcinoma (AGS) and esophageal squamous cell carcinoma (KYSE30) cell lines. Gastroenterol. Hepatol. Bed Bench 2017, 10, 102. [Google Scholar]
  173. Anadón, A.; Martínez-Larrañaga, M.R.; Martínez, M.A.; Ares, I.; García-Risco, M.R.; Señoráns, F.J.; Reglero, G. Acute oral safety study of rosemary extracts in rats. J. Food Prot. 2008, 71, 790–795. [Google Scholar] [CrossRef]
  174. Mandal, D.; Sarkar, T.; Chakraborty, R. Critical Review on Nutritional, Bioactive, and Medicinal Potential of Spices and Herbs and Their Application in Food Fortification and Nanotechnology. Appl. Biochem. Biotechnol. 2023, 195, 1319–1513. [Google Scholar] [CrossRef]
  175. Ke, Y.; Geng, C.; Lin, L.; Zhao, M.; Rao, H. Pectin-type polysaccharide from galangal: An efficient emulsifier to construct the emulsion-based delivery system for galangal flavonoids. Int. J. Biol. Macromol. 2022, 221, 644–652. [Google Scholar] [CrossRef]
  176. Simon, A.; Nghiem, K.S.; Gampe, N.; Garádi, Z.; Boldizsár, I.; Backlund, A.; Darcsi, A.; Nedves, A.N.; Riethmüller, E. Stability Study of Alpinia galanga Constituents and Investigation of Their Membrane Permeability by ChemGPS-NP and the Parallel Artificial Membrane Permeability Assay. Pharmaceutics 2022, 14, 1967. [Google Scholar] [CrossRef]
  177. Tian, Y.; Jia, X.; Wang, Q.; Lu, T.; Deng, G.; Tian, M.; Zhou, Y. Antioxidant, Antibacterial, Enzyme Inhibitory, and Anticancer Activities and Chemical Composition of Alpinia galanga Flower Essential Oil. Pharmaceuticals 2022, 15, 1069. [Google Scholar] [CrossRef]
  178. Kazemi, S.; Asadi, F.; Barari, L.; Morakabati, P.; Jahani, M.; Kani, S.N.M.; Soorani, F.; Kolangi, F.; Memariani, Z. Quantification of Flavonoids in Alpinia officinarum Hance. via HPLC and Evaluation of its Cytotoxicity on Human Prostate Carcinoma (LNCaP) and Breast Carcinoma (MCF-7) Cells. Anticancer Agents Med. Chem. 2022, 22, 721–730. [Google Scholar] [CrossRef]
  179. Fu, J.; Wang, Y.; Sun, M.; Xu, Y.; Chen, L. Antibacterial Activity and Components of the Methanol-Phase Extract from Rhizomes of Pharmacophagous Plant Alpinia officinarum Hance. Molecules 2022, 27, 4308. [Google Scholar] [CrossRef]
  180. Tang, X.; Xu, C.; Yagiz, Y.; Simonne, A.; Marshall, M.R. Phytochemical profiles, and antimicrobial and antioxidant activities of greater galangal [Alpinia galanga (Linn.) Swartz.] flowers. Food Chem. 2018, 255, 300–308. [Google Scholar] [CrossRef]
  181. Yuandani; Jantan, I.; Haque, M.A.; Rohani, A.S.; Nugraha, S.E.; Salim, E.; Septama, A.W.; Juwita, N.A.; Khairunnisa, N.A.; Nasution, H.R.; et al. Immunomodulatory effects and mechanisms of the extracts and secondary compounds of Zingiber and Alpinia species: A review. Front. Pharmacol. 2023, 14, 1222195. [Google Scholar] [CrossRef]
  182. Hadjzadeh, M.A.R.; Ghanbari, H.; Keshavarzi, Z.; Tavakol-Afshari, J. The Effects of Aqueous Extract of Alpinia Galangal on Gastric Cancer Cells (AGS) and L929 Cells in Vitro. Iran. J. Cancer Prev. 2014, 7, 142. [Google Scholar]
  183. Ma, Y.L.; Zhao, F.; Yin, J.T.; Liang, C.J.; Niu, X.L.; Qiu, Z.H.; Zhang, L.T. Two Approaches for Evaluating the Effects of Galangin on the Activities and mRNA Expression of Seven CYP450. Molecules 2019, 24, 1171. [Google Scholar] [CrossRef]
  184. Rampogu, S.; Gajula, R.G.; Lee, K.W. A comprehensive review on chemotherapeutic potential of galangin. Biomed. Pharmacother. 2021, 141, 111808. [Google Scholar] [CrossRef]
  185. Zhang, C.R.; Dissanayake, A.A.; Kevseroǧlu, K.; Nair, M.G. Evaluation of coriander spice as a functional food by using in vitro bioassays. Food Chem. 2015, 167, 24–29. [Google Scholar] [CrossRef]
  186. Balasubramanian, S.; Roselin, P.; Singh, K.K.; Zachariah, J.; Saxena, S.N. Postharvest Processing and Benefits of Black Pepper, Coriander, Cinnamon, Fenugreek, and Turmeric Spices. Crit. Rev. Food Sci. Nutr. 2016, 56, 1585–1607. [Google Scholar] [CrossRef]
  187. Shukla, S.; Gupta, S. Coriander. In Molecular Targets and Therapeutic Uses of Spices: Modern Uses for Ancient Medicine; World Scientific: Singapore, 2022; pp. 149–172. [Google Scholar] [CrossRef]
  188. Cherng, J.M.; Shieh, D.E.; Chiang, W.; Chang, M.Y.; Chiang, L.C. Chemopreventive effects of minor dietary constituents in common foods on human cancer cells. Biosci. Biotechnol. Biochem. 2007, 71, 1500–1504. [Google Scholar] [CrossRef]
  189. Mirza, M.A.; Mahmood, S.; Hilles, A.R.; Ali, A.; Khan, M.Z.; Zaidi, S.A.A.; Iqbal, Z.; Ge, Y. Quercetin as a Therapeutic Product: Evaluation of Its Pharmacological Action and Clinical Applications—A Review. Pharmaceuticals 2023, 16, 1631. [Google Scholar] [CrossRef]
  190. Yang, L.; Hu, Z.; Zhu, J.; Liang, Q.; Zhou, H.; Li, J.; Fan, X.; Zhao, Z.; Pan, H.; Fei, B. Systematic Elucidation of the Mechanism of Quercetin against Gastric Cancer via Network Pharmacology Approach. BioMed Res. Int. 2020, 2020, 3860213. [Google Scholar] [CrossRef]
  191. Haghi, A.; Azimi, H.; Rahimi, R. A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer. J. Gastrointest. Cancer 2017, 48, 314–320. [Google Scholar] [CrossRef]
  192. Li, H.; Chen, C. Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα. Integr. Cancer Ther. 2018, 17, 511–523. [Google Scholar] [CrossRef] [PubMed]
  193. Xiang, J.; Mlambo, R.; Shaw, I.; Seid, Y.; Shah, H.; He, Y.; Kpegah, J.K.S.K.; Tan, S.; Zhou, W.; He, B. Cryopreservation of bioflavonoid-rich plant sources and bioflavonoid-microcapsules: Emerging technologies for preserving bioactivity and enhancing nutraceutical applications. Front. Nutr. 2023, 10, 1232129. [Google Scholar] [CrossRef]
  194. Dos Santos Szewczyk, K.; Skowrońska, W.; Kruk, A.; Makuch-Kocka, A.; Bogucka-Kocka, A.; Miazga-Karska, M.; Grzywa-Celińska, A.; Granica, S. Chemical composition of extracts from leaves, stems and roots of wasabi (Eutrema japonicum) and their anti-cancer, anti-inflammatory and anti-microbial activities. Sci. Rep. 2023, 13, 9142. [Google Scholar] [CrossRef] [PubMed]
  195. Park, J.E.; Lee, T.H.; Ham, S.L.; Subedi, L.; Hong, S.M.; Kim, S.Y.; Choi, S.U.; Kim, C.S.; Lee, K.R. Anticancer and Anti-Neuroinflammatory Constituents Isolated from the Roots of Wasabia japonica. Antioxidants 2022, 11, 482. [Google Scholar] [CrossRef] [PubMed]
  196. Tarar, A.; Peng, S.; Cheema, S.; Peng, C.A. Anticancer Activity, Mechanism, and Delivery of Allyl Isothiocyanate. Bioengineering 2022, 9, 470. [Google Scholar] [CrossRef] [PubMed]
  197. Hou, D.X.; Fukuda, M.; Fujii, M.; Fuke, Y. Transcriptional regulation of nicotinamide adenine dinucleotide phosphate: Quinone oxidoreductase in murine hepatoma cells by 6-(methylsufinyl)hexyl isothiocyanate, an active principle of wasabi (Eutrema wasabi Maxim). Cancer Lett. 2000, 161, 195–200. [Google Scholar] [CrossRef]
  198. Wang, Q.; Bao, Y. Nanodelivery of natural isothiocyanates as a cancer therapeutic. Free Radic. Biol. Med. 2021, 167, 125–140. [Google Scholar] [CrossRef]
  199. Tanida, N.; Kawaura, A.; Takahashi, A.; Sawada, K.; Shimoyama, T. Suppressive effect of wasabi (pungent Japanese spice) on gastric carcinogenesis induced by MNNG in rats. Nutr. Cancer 1991, 16, 53–58. [Google Scholar] [CrossRef]
  200. Nakajima, R.; Kanou, M.; Tokushima, M.; Iwama, Y.; Yamana, K. Oral administration of 6-methylsulfinylhexyl isothiocyanate extracted from wasabi is safe and improves the fatigue and sleep of healthy volunteers. Biopsychosoc. Med. 2023, 17, 30. [Google Scholar] [CrossRef]
  201. Janczewski, Ł. Sulforaphane and Its Bifunctional Analogs: Synthesis and Biological Activity. Molecules 2022, 27, 1750. [Google Scholar] [CrossRef]
  202. Li, S.; Khoi, P.N.; Yin, H.; Sah, D.K.; Kim, N.H.; Lian, S.; Jung, Y. Do Sulforaphane Suppresses the Nicotine-Induced Expression of the Matrix Metalloproteinase-9 via Inhibiting ROS-Mediated AP-1 and NF-κB Signaling in Human Gastric Cancer Cells. Int. J. Mol. Sci. 2022, 23, 5172. [Google Scholar] [CrossRef]
  203. Dong, Q.Q.; Wang, Q.T.; Wang, L.; Jiang, Y.X.; Liu, M.L.; Hu, H.J.; Liu, Y.; Zhou, H.; He, H.P.; Zhang, T.C.; et al. SMYD3-associated pathway is involved in the anti-tumor effects of sulforaphane on gastric carcinoma cells. Food Sci. Biotechnol. 2018, 27, 1165–1173. [Google Scholar] [CrossRef]
  204. Dutta, A.; Chakraborty, A. Cinnamon in Anticancer Armamentarium: A Molecular Approach. J. Toxicol. 2018, 2018, 8978731. [Google Scholar] [CrossRef]
  205. Günes-Bayir, A.; Kocyigit, A.; Güler, E.M.; Bilgin, M.G.; Ergün, İ.S.; Dadak, A. Effects of carvacrol on human fibroblast (WS-1) and gastric adenocarcinoma (AGS) cells in vitro and on Wistar rats in vivo. Mol. Cell. Biochem. 2018, 448, 237–249. [Google Scholar] [CrossRef] [PubMed]
  206. Günes-Bayir, A.; Kocyigit, A.; Güler, E.M. In vitro effects of two major phenolic compounds from the family Lamiaceae plants on the human gastric carcinoma cells. Toxicol. Ind. Health 2018, 34, 525–539. [Google Scholar] [CrossRef] [PubMed]
  207. Günes-Bayir, A.; Kocyigit, A.; Guler, E.M.; Dadak, A. In Vitro Hormetic Effect Investigation of Thymol on Human Fibroblast and Gastric Adenocarcinoma Cells. Molecules 2020, 25, 3270. [Google Scholar] [CrossRef]
  208. Ballester, P.; Cerdá, B.; Arcusa, R.; García-Muñoz, A.M.; Marhuenda, J.; Zafrilla, P. Antioxidant Activity in Extracts from Zingiberaceae Family: Cardamom, Turmeric, and Ginger. Molecules 2023, 28, 4024. [Google Scholar] [CrossRef] [PubMed]
  209. Manjunath, C.; Mahurkar, N. In vitro cytotoxicity of cardamom oil, lemon oil, and jasmine oil on human skin, gastric, and brain cancer cell line. J. Cancer Res. Ther. 2021, 17, 62–68. [Google Scholar] [CrossRef] [PubMed]
  210. El Bairi, K.; Ouzir, M.; Agnieszka, N.; Khalki, L. Anticancer potential of Trigonella foenum graecum: Cellular and molecular targets. Biomed. Pharmacother. 2017, 90, 479–491. [Google Scholar] [CrossRef] [PubMed]
  211. Ren, Q.L.; Wang, Q.; Zhang, X.Q.; Wang, M.; Hu, H.; Tang, J.J.; Yang, X.T.; Ran, Y.H.; Liu, H.H.; Song, Z.X.; et al. Anticancer Activity of Diosgenin and Its Molecular Mechanism. Chin. J. Integr. Med. 2023, 29, 738–749. [Google Scholar] [CrossRef] [PubMed]
  212. Aćimović, M.; Filipović, V.; Stanković, J.; Cvetković, M.; Đukanović, L. The Influence of Environmental Conditions on Carum carvi L. var. annum Seed Quality. Ratar. Povrt. 2015, 52, 91–96. [Google Scholar] [CrossRef]
  213. Naderi-Kalali, B.; Allameh, A.; Rasaee, M.J.; Bach, H.J.; Behechti, A.; Doods, K.; Kettrup, A.; Schramm, K.W. Suppressive effects of caraway (Carum carvi) extracts on 2, 3, 7, 8-tetrachloro-dibenzo-p-dioxin-dependent gene expression of cytochrome P450 1A1 in the rat H4IIE cells. Toxicol. In Vitro 2005, 19, 373–377. [Google Scholar] [CrossRef]
  214. Zhang, X.Z.; Wang, L.; Liu, D.W.; Tang, G.Y.; Zhang, H.Y. Synergistic Inhibitory Effect of Berberine and d-Limonene on Human Gastric Carcinoma Cell Line MGC803. J. Med. Food 2014, 17, 955. [Google Scholar] [CrossRef]
  215. Kasetti, R.B.; Nabi, S.A.; Swapna, S.; Apparao, C. Cinnamic acid as one of the antidiabetic active principle(s) from the seeds of Syzygium alternifolium. Food Chem. Toxicol. 2012, 50, 1425–1431. [Google Scholar] [CrossRef]
  216. Rani, R.; Kumar, M. Plant Archives clove (Syzygium aromaticum): Beneficial effects on human health: A review. Jena Plant Arch. 2021, 21, 1967–1972. [Google Scholar] [CrossRef]
  217. Kashyap, D.; Baral, B.; Verma, T.P.; Sonkar, C.; Chatterji, D.; Jain, A.K.; Jha, H.C. Oral rinses in growth inhibition and treatment of Helicobacter pylori infection. BMC Microbiol. 2020, 20, 45. [Google Scholar] [CrossRef]
  218. Santin, J.R.; Lemos, M.; Klein-Júnior, L.C.; Machado, I.D.; Costa, P.; De Oliveira, A.P.; Tilia, C.; De Souza, J.P.; De Sousa, J.P.B.; Bastos, J.K.; et al. Gastroprotective activity of essential oil of the Syzygium aromaticum and its major component eugenol in different animal models. Naunyn-Schmiedeberg Arch. Pharmacol. 2011, 383, 149–158. [Google Scholar] [CrossRef]
  219. Capasso, R.; Pinto, L.; Vuotto, M.L.; Di Carlo, G. Preventive effect of eugenol on PAF and ethanol-induced gastric mucosal damage. Fitoterapia 2000, 71, S131–S137. [Google Scholar] [CrossRef]
  220. Hobani, Y.H.; Mohan, S.; Shaheen, E.; Abdelhaleem, A.; Faruque Ahmad, M.; Bhatia, S.; Abou-Elhamd, A.S. Gastroprotective effect of low dose Eugenol in experimental rats against ethanol induced toxicity: Involvement of antiinflammatory and antioxidant mechanism. J. Ethnopharmacol. 2022, 289, 115055. [Google Scholar] [CrossRef]
  221. Jahangir, M.A.; Taleuzzaman, M.; Beg, S.; Verma, S.; Gilani, S.J.; Alam, P. A Review of Eugenol-based Nanomedicine: Recent Advancements. Curr. Bioact. Compd. 2020, 17, 214–219. [Google Scholar] [CrossRef]
  222. Begum, S.N.; Ray, A.S.; Rahaman, C.H. A comprehensive and systematic review on potential anticancer activities of eugenol: From pre-clinical evidence to molecular mechanisms of action. Phytomedicine 2022, 107, 154456. [Google Scholar] [CrossRef]
  223. Mashraqi, A. Induction role of chitosan nanoparticles to Anethum graveolens extract against food-borne bacteria, oxidant, and diabetic activities in vitro. Front. Microbiol. 2023, 14, 1209524. [Google Scholar] [CrossRef]
  224. Sadeghian, S.; Neyestani, T.R.; Shirazi, M.H.; Ranjbarian, P. Bacteriostatic effect of dill, fennel, caraway and cinnamon extracts against Helicobacter pylori. J. Nutr. Environ. Med. 2005, 15, 47–55. [Google Scholar] [CrossRef]
  225. Mohsin, M.M.; Hanif, M.A.; Ayub, M.A.; Bhatti, I.A.; Jilani, M.I. Dill. In Medicinal Plants of South Asia Novel Sources for Drug Discovery; Elsevier: Amsterdam, The Netherlands, 2023; pp. 231–239. [Google Scholar] [CrossRef]
  226. Noumi, E.; Ahmad, I.; Adnan, M.; Merghni, A.; Patel, H.; Haddaji, N.; Bouali, N.; Alabbosh, K.F.; Ghannay, S.; Aouadi, K.; et al. GC/MS Profiling, Antibacterial, Anti-Quorum Sensing, and Antibiofilm Properties of Anethum graveolens L. Essential Oil: Molecular Docking Study and In-Silico ADME Profiling. Plants 2023, 12, 1997. [Google Scholar] [CrossRef] [PubMed]
  227. Desta, K.T.; Kim, G.S.; El-Aty, A.M.A.; Raha, S.; Kim, M.B.; Jeong, J.H.; Warda, M.; Hacımüftüoğlu, A.; Shin, H.C.; Shim, J.H.; et al. Flavone polyphenols dominate in Thymus schimperi Ronniger: LC–ESI–MS/MS characterization and study of anti-proliferative effects of plant extract on AGS and HepG2 cancer cells. J. Chromatogr. B 2017, 1053, 1–8. [Google Scholar] [CrossRef]
  228. Sun, X.; Chen, W.; Dai, W.; Xin, H.; Rahmand, K.; Wang, Y.; Zhang, J.; Zhang, S.; Xu, L.; Han, T. Piper sarmentosum Roxb.: A review on its botany, traditional uses, phytochemistry, and pharmacological activities. J. Ethnopharmacol. 2020, 263, 112897. [Google Scholar] [CrossRef]
Figure 1. The potential factors that increase the risk of GC.
Figure 1. The potential factors that increase the risk of GC.
Cancers 16 01611 g001
Table 1. Potential use the spices for the prevention of GC.
Table 1. Potential use the spices for the prevention of GC.
SpiceActive CompoundsUse in GC PreventionAdditional Information
Turmeric
[16,17,18,19]
curcuminexhibits anti-inflammatory, antioxidant properties; antibacterial properties are related to the inhibition of H. pylori infection;-
Ginger
[20,21,22]
6-gingerol
8-paradol
shows anti-inflammatory effects and inhibition of H. pylori infection;-
Garlic
[23,24]
allicinlack of strong evidence regarding the use of garlic in the prevention of GC-
Black cumin
[25,26]
thymoquinoneshows activity against H. pylori infectioncombination of black cumin with honey (12 also shows activity against H. pylori
Black pepper
[27,28,29]
piperineinhibition of gastritis caused by H. pylori, reduction of the number of H. pylori colonies, inhibition of H. pylori adhesion to GC cells and reduction of their motility, inhibition of the translocation of H. pylori toxins-
Galangal
[30,31,32,33,34,35]
galanginexhibits anti-inflammatory, antioxidant, antimicrobial effects (inhibitory effect on H. pylori),anticancer potential of galangin by inhibiting benzoapirene-induced gastric cancer development
Coriander
[33]
inhibitory effect on ROS and IL8 generation of coriander extract on H. pylori-infected AGS cells,
Wasabi
[36]
allyl isothiocyanatereduction of symptoms associated with H. pylori infection-
Oregano
[37]
thymol
ρ-cymene
γ-terpinene
carvacrol
exhibits anti-inflammatory propertiesreduction of expression cytokines (IL-1β, IL-6, and TNF-α), and other inflammatory mediators (VEGF and TGF-β)
Cardamon
[38]
1,8-cineole, α-terpinyl acetate, nerolidol, sabinene, g-terpinene, α-pinene, methyl linoleate, α-terpineol, β-pinene, n-hexadecanoic acid, and limonenereduction of tumor incidence and multiplicitycardamon modulates phase II detoxifying enzymes, particularly GST, activates antioxidant enzymes, elevates GSH levels, and inhibits lipid peroxidation levels and LDH activity
Caraway
[4,39,40,41,42]
d-carvone, limonene, nsLTPsexhibits antioxidant, anti-inflammatory, and anticancer effects, inhibit cell proliferation, increase ROS production, and induce apoptosis-
Clove
[43,44,45,46,47,48]
eugenol, 5-hydroxy-7,4′-dimethoxy-6,8-di-C-methylflavone (eucalyptin), kaempferol 3-O-β-d-glucopyranoside, kaempferol 3-O-α-l-rhamnopyranosideexhibits inhibitory effect on AGS gastric cancer cell proliferation, oxidant and cytotoxic effect on cancer cells, has antibacterial activity against H. pylori-
Dill
[49,50,51,52]
carvone, d-limoneneantioxidant, anti-radicals, antisecretory and anti-ulcer effects, antimicrobial activity against H. pylori-
Thyme
[53,54,55]
thymol, p-cymene, eugenol, carvacolic acid, chlorogenic acid,exhibits genotoxic and cytotoxic effects on AGS cells, induces apoptosis in human AGS cells-
Piper sarmentosum
[56]
volatile oil, alkaloids, sterols, and lignansPiper sarmentosum supplementation significantly reduced the results of gastric lesions. Oral Piper sarmentosum supplementation supports protection against the occurrence of gastric lesions-
Table 2. Potential use the spices for the treatment of GC.
Table 2. Potential use the spices for the treatment of GC.
SpiceActive CompoundsUse in GC TreatmentMechanismAdditional Information
Tumeric
[57,58,59,60,61,62,63]
curcumininhibits proliferation, migration, inducts apoptosissuppression of the Shh, Wnt, PI3K signaling pathways; activation of the P53 signaling pathway; epigenetic modificationepigenetic modifications involve upregulation of histone acetylation and deacetylation enzymes, upregulation of mir34, mir33b, downregulation of mir21 expression
Ginger
[64,65,66,67]
6-gingerol
8-paradol
inhibits GC cell proliferation; induces apoptosis; increases the radiosensitivity of GC cells; increases the sensitivity of GC cells to cisplatin8-Paradol induces tumor cell apoptosis by promoting PINK1/Parkin-mediated mitophagy of cells-
Garlic
[68,69,70,71,72,73,74,75,76,77,78,79]
allicin
diallyl disulfide
diallyl trisulfide
s-allilocysteine
induces apoptosis, inhibits proliferation, and arrests GC cells in the G2/M phase of the cell cycleallicin induces cytochrome release from mitochondria, hydroxylation of caspases, activation of p38 MAPK/caspase 3 pathway; diallyl disulfide is associated with the arrest of GC cells in the G2/M phase of the cell cycle; diallyl trisulfide activates AMPKGarlic supplementation appears to have a beneficial effect on reducing the risk of death from GC; s-allilocysteine inhibits the activation of inflammatory mediators, which can be used to treat gastric ulcers
Black cumin
[80,81,82,83]
thymoquinoneinhibits proliferation and induces apoptosisinhibition of PI3K/Akt/mTOR and STAT3 pathway; potentiation the effects of 5-fluorouracil-
Chili pepper
[84,85,86,87,88]
capsaicininhibits proliferation and induces apoptosis of GC cellsincreases production of caspase-3; reduces the expression of Bcl-2; reduces the expression of phosphorylated ERK 1/2, p38 MAPK, or JNK
epigenetic modifications: restoring the activity of hMOF HATs
may increase the risk of GC
Saffron
[89,90,91,92]
crocin
crocetin
inhibition of GC cell proliferation;
stimulation of apoptosis
stimulation of apoptosis
inhibition of angiogenesis
reduction of expression TPM4
increase in Bax/Bcl-2 ratio and activation of caspases
reduction of the Bcl-2/Bax ratio
inhibition of the sonic hedgehog signaling pathway
-
Black pepper
[93,94]
piperineinhibition of GC cell proliferation and induction of apoptosis
inhibition of IL-6
inhibition of the PI3K/Akt signaling pathway
suppression of p38 MAPK and STAT3
-
Rosemary
[95,96]
carnosol
sageon
induction of apoptosis, inhibition of the growth of GC cells, reduction in the volume and weight of the gastric tumor
induction of apoptosis
inhibition of the RSK/CREB signaling pathway
loss of the MMP and activation of caspase proteins
-
Galangal
[31,32,97,98,99]
galanginInduction of apoptosis
inhibiting cell growth
decreasing cell viability
decreased expression of Bcl-2 and CASP3, increased protein expression of cleaved CASP3 and cleaved PARP, reduced expression of PCNA and Ki67
mitochondrial pathway involving CASP8/Bid/Bax activation
decreased expression of Bcl-2 and Bcl-xl, increased expression of Bax protein
increased expression of CASP3, CASP9, and PARP polymerase,
inhibition of ERK1/2 activity and stimulation of c-JNK
reduction in the ratio of p-JAK2/JAK2 and p-STAT3/STAT3 and protein expression of Bcl-2, CASP3, and Ki67 increased protein expression of cleaved CASP3 and cleaved PARP
suppression of NF-κB pathway and enhancement of autophagy
modulation of STAT3 activation and increase in ROS
Increased expression of Uch-L1 while decreased expression of GSTP can suggest an antitumor effect of galangin by a particular mechanism
Coriander
[100,101,102,103,104,105]
quercetininhibiting cell growth
induction of apoptosis
increased expression of pyroptosis proteins: GSDMD, GSDME, CASP1, NLRP3, and apoptosis markers CASP3 and PARP
Affecting TP53, MYC, and TIMP1
CASP3 and CASP9 activation, Bcl-2 downregulation Bax, and cyt-c upregulation
Quercetin is suggested to have a positive effect on reducing the degree of resistance of gastric cancer cell lines to daunorubicin (EPG85-257RDB) or oxaliplatin (KATOIII/OxR) and increased efficacy of chemotherapy with irinotecan/SN-38
Wasabi
[106,107,108,109,110,111]
allyl isothiocyanate
sulforaphane
inhibition of cell migration and invasion
decreasing cell viability
inhibition of cancer cell activity
inhibition of cancer cell proliferation
induction of apoptosis
inhibition of PI3K/AKT, uPA, and MAPK signaling pathways;
decreased MMP-2 and MMP-9 activity
changes in the expression of DNA damage and repair proteins
PDL-1 induction
glycolysis inhibition
involvement of miR-4521-dependent mediator
-
Cinnamon
[112,113,114]
eugenol
cinnamaldehyde
beta-caryophyllene
beta-caryophyllene oxide
reduction of tumor growth, inhibition of GC cell proliferation
induction of apoptosis
inhibits the proliferation of GC cells and induces endoplasmic reticulum stress and autophagic cell death
antiproliferative effect of eugenol for NF-κB family members and the NF-κB target genes
eugenol stimulates the expression of caspase-8 and caspase-3
cinnamaldehyde activates the PERK-CHOP signaling pathway, inhibits G9a binding on the Beclin-1 and LC3B promoter, and disrupts the Bcl-2–Beclin-1 interaction
decrease in substances responsible for cell cycle promotion and an increase in those responsible for cell cycle inhibition
eugenol can stimulate caspase-8 and caspase-3 even when p53 is absent
Oregano
[37,53,115]
thymol
carvacrol
ρ-cymene
γ-terpinene
inhibition of GC cell proliferation and migration (oregano oil)
decrease in protein accumulation involved in the fatty acid and cholesterol biosynthesis pathway (oregano oil)
carvacrol induces apoptosis via the mitochondrial pathway
carvacrol exhibits pro-oxidant properties
reduction of expression HMGCR, ACC, SPREPB1, FASN
reduction of the Bcl-2/Bax ratio and activation of caspase 9
ROS-generating effect
potential apoptotic activity of carvacrol at high doses
Fenugreek
[116,117,118]
steroidal sapogenins e.g., diosgenin, trigonelline, choline, gentianine and carpain, quercetin, luteolin, vitexin cinnamate, vicenin, and isovitexin, saponinsdiosgenin:
inhibition of GC cell proliferation
inhibition of GC invasion
decrease in the cell viability
arrest of GC cells in the G0/G1 phase of the cell cycle
induce apoptosis
reduction expression of MESP1, induction expression of ARF
stimulation of expression of cell adhesion molecules, e.g., E-cadherin
Caraway
[4,41,119]
d-carvone
limonene
inhibits cell proliferation, increases ROS production, and induces apoptosis and loss of mitochondrial membrane potential
In a study on nude mice with human gastric cancer implanted, d-limonene, a decrease in tumor weight and a decrease in the incidence of liver and peritoneal metastases were seen
downregulates the JAK/STAT2 signaling pathway in gastric cancer AGS cells and inhibits JAK/STAT3 signaling pathway in gastric cancer AGS cells
exhibits cytotoxic effects in cells in the MGC803, induces apoptosis, has antioxidant effects, reduces MMP and lower Blc-2 expression, increases caspase-3 expression
this effect is stronger when d-limonene with berberine is used simultaneously
Clove
[44,45,113,120,121]
eugenol
flavonoids: 5-hydroxy-7,4′-dimethoxy-6,8-di-C-methylflavone (eucalyptin), kaempferol 3-O-β-d-glucopyranoside, and kaempferol 3-O-α-l-rhamnopyranoside
shows an inhibitory effect on AGS gastric cancer cell proliferation
inhibited the proliferation of human GC cells
induces apoptosis of cancer cells early; mainly causing a decrease in the S-phase population; induces caspase-8 and caspase-3 in the absence of p53; has anti-metastatic activities on AGS cell line independent of p53, P21, and SMAD4; inhibits the secretion of TGF-β type 2 isoform and intracellular expression of TGF-β.
stops the G2/M phase of the cell cycle of human GC cells
Eugenol derivatives of β-aminoalcohol were more cytotoxic to A549 and AGS cells compared to β-alkoxyalcohol derivatives and the parent substance
Thyme
[53,54,55]
thymol
carvacrol
chlorogenic acid
exhibits genotoxic and cytotoxic effects on AGS cells
inhibited cell proliferation-induced DNA damage, apoptosis, and ROS production
shows affinity for GC target genes, strong anticancer activity against various cancer and non-cancer cell lines
induces apoptosis by producing ROS and regulates the cell cycle by prolonging the sub-G1 cellular phase in AGS cells, damages MMPs and activates proapoptotic proteins; Bax; PARP; and caspase-7, -8, and -9, increases in caspase-3
exhibits antiproliferative effects and induction of apoptosis, which are regulated by Bax, Bcl-2, caspase-3, and caspase-9 proteins
there are different data on the effect on Bcl-2 expression; depending on the study, thymol has no effect on Bcl-2 expression or causes a decrease in it
Basil
[122]
anthocyanin and flavonoid derivativescell death and inhibition of cell viability, cytotoxicity, antioxidant activity, apoptosis, reduced tumor growth, and cell cycle arrestno exact data discovered-
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kostelecka, K.; Bryliński, Ł.; Komar, O.; Michalczyk, J.; Miłosz, A.; Biłogras, J.; Woliński, F.; Forma, A.; Baj, J. An Overview of the Spices Used for the Prevention and Potential Treatment of Gastric Cancer. Cancers 2024, 16, 1611. https://doi.org/10.3390/cancers16081611

AMA Style

Kostelecka K, Bryliński Ł, Komar O, Michalczyk J, Miłosz A, Biłogras J, Woliński F, Forma A, Baj J. An Overview of the Spices Used for the Prevention and Potential Treatment of Gastric Cancer. Cancers. 2024; 16(8):1611. https://doi.org/10.3390/cancers16081611

Chicago/Turabian Style

Kostelecka, Katarzyna, Łukasz Bryliński, Olga Komar, Justyna Michalczyk, Agata Miłosz, Jan Biłogras, Filip Woliński, Alicja Forma, and Jacek Baj. 2024. "An Overview of the Spices Used for the Prevention and Potential Treatment of Gastric Cancer" Cancers 16, no. 8: 1611. https://doi.org/10.3390/cancers16081611

APA Style

Kostelecka, K., Bryliński, Ł., Komar, O., Michalczyk, J., Miłosz, A., Biłogras, J., Woliński, F., Forma, A., & Baj, J. (2024). An Overview of the Spices Used for the Prevention and Potential Treatment of Gastric Cancer. Cancers, 16(8), 1611. https://doi.org/10.3390/cancers16081611

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop